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Resumen 
Los canales de potasio dependientes de voltaje (Kv) son proteínas de membrana que se encuentran 
altamente moduladas en diversos procesos fisiológicos, y patológicos tales como la respuesta inmune y la 
función cardiaca. Los canales iónicos, y en particular los canales de potasio, juegan un papel esencial en la 
fisiología de los macrófagos. Se ha descrito que un incremento en la dieta de ácidos grasos poliinsaturados 
(AGPIs) posee propiedades antiinflamatorias. Es más, mediadores lipídicos derivados de AGPIs n-6 y n-3, como 
lipoxinas y resolvinas (cuya producción aumenta tras la ingesta de aspirina), han surgido como nuevos y 
potentes agentes que regulan la inflamación aguda promoviendo la resolución. En la presente Tesis Doctoral se 
estudió la modulación por lipoxinas de los canales Kv y Kir presentes en macrófagos derivados de médula ósea 
(MDMO) mediante la técnica de patch-clamp. El tratamiento agudo con e-LXA4 de MDMO estimulados con LPS 
disminuyó la corriente Kv, lo que es compatible con la atenuación de la respuesta inflamatoria. De manera más 
relevante, el pretratamiento con e-LXA4 de MDMO estimulados con LPS revertió los efectos producidos en las 
corrientes Kv y Kir, en los niveles de Ca2+ intracelular, disminuyó la actividad de NF-κB e IKKβ y protegió contra la 
apoptosis inducida por LPS. Estos efectos fueron mediados, al menos en parte, a través de la vía dependiente 
del receptor de lipoxinas (ALX). Este trabajo describe un nuevo mecanismo por el cual la e-LXA4 contribuye a la 
resolución de la inflamación que consiste en la prevención de los efectos del LPS sobre las corrientes Kv y Kir de 
MDMO. Además, se ha descrito que los AGPIs modifican la actividad eléctrica del corazón a través de la 
modulación de canales iónicos. En la presente Tesis Doctoral, se analizaron los efectos de la aplicación aguda y 
crónica de EPA y DHA en la corriente generada por Kv7.1/KCNE1 expresados transitoriamente en células COS7 
mediante la técnica de patch-clamp, western blot y aislamiento de balsas lipídicas. En función del modo de 
administración, los AGPIs modificaron dicha corriente de manera diferencial. La perfusión aguda con EPA 
aumentó la magnitud de Kv7.1/KCNE1, enlenteció la cinética de activación y desplazó la curva de activación (CA) 
hacia la izquierda. Por el contrario, el EPA crónico no modificó la corriente Kv7.1/KCNE1 pero desplazó la CA en 
dirección opuesta. Además, EPA crónico disminuyó la expresión de Kv7.1 pero no de KCNE1, e indujo una 
redistribución de Kv7.1 en la membrana celular. Experimentos con metil--ciclodextrina mostraron que la 
depleción de colesterol aumenta la magnitud de Kv7.1/KCNE1. En estas células, EPA ejerció efectos similares a 
los producidos tras su administración aguda, efectos que fueron revertidos tras el posterior lavado con solución 
libre de AGPI, sugiriendo una interacción directa con el canal. Por otro lado, mutaciones en canales iónicos 
cardiacos alteran la formación y propagación normal de los potenciales de acción, lo que puede generar la 
aparición de arritmias. El síndrome de QT corto es una nueva entidad clínica que se caracterizada por un 
acortamiento del intervalo QTc en el ECG y por una falta de adaptación durante el ejercicio. En la presente Tesis 
Doctoral, se caracterizó mediante la técnica de patch-clamp la nueva mutación F279I Kv7.1 encontrada en un 
varón de 23 años con un QTc de 356 ms con una historia clínica familiar de MSC. En ausencia de KCNE1, la 
corriente silvestre y F279I Kv7.1 exhibieron propiedades biofísicas similares. Sin embargo, el canal F279I Kv7.1 
expresado en homo o heterozigosis con el canal silvestre y en presencia de KCNE1 mostró un pronunciado 
desplazamiento de la CA y una aceleración de la cinética de activación, permitiendo una ganancia de función en 
IKs. Se concluye, por tanto, que la mutación F279I provoca un aumento sustancial en la corriente de 
repolarización durante el PA debido a una modulación defectuosa de KCNE1 del “gating” de Kv7.1. 

Abstract 
Voltage dependent potassium channels (Kv) are membrane proteins highly modulated by several 
physiological, pharmacological and pathological events. Also, Kv channels are involved in a plethora of 
pathophysiological process, including immune response and cardiac arrhythmias. Ion channels and in particular, 
potassium channels play a pivotal role in the modulation of macrophage physiology. It has been described that an 
increased consumption of PUFAs in the diet possesses anti-inflammatory actions. In fact n-6 and n-3 derived lipid 
mediators, such as the lipoxins and resolvins (whose production is increase in the presence of aspirin) have 
emerged as novel potent agents that counter-regulate excessive acute inflammation and stimulate molecular and 
cellular events that define resolution. In the present Doctoral Thesis, the modulation of Kv and Kir channels by 
lipoxins was analyzed. Currents were recorded in bone marrow derived macrophages (BMDM) using the patch-
clamp technique. Acute treatment of LPS-stimulated BMDM with e-LXA4 resulted in a decrease of Kv currents, 
compatible with attenuation of the inflammatory response. More importantly, long-term treatment of LPS-
stimulated BMDM with e-LXA4 significantly reverted LPS effects on Kv and Kir currents, intracellular calcium 
levels, diminished NF-κB and IKKβ activity, and protected against LPS activation-dependent apoptosis. These 
effects were mediated, at least in part, via the lipoxin receptor (ALX). We provide evidence for a new mechanism 
by which e-LXA4 contributes to inflammation resolution consisting in the revertion of LPS effects on Kv and Kir 
currents in macrophages. In addition, it has been report that PUFAs can modify the electrical activity of the heart 
due to their ability to modulate cardiac ion channels. In the present Doctoral Thesis, we analyzed the effects of 
acute and chronic application of EPA and DHA on the current and the expression of Kv7.1/KCNE1 channels 
transiently expressed in COS7 cells by using patch-clamp, Western blot, and lipid rafts extraction techniques. 
Depending on the way of administration, PUFAs differentially modified this current. Acute perfusion with EPA 
increased Kv7.1/KCNE1 current magnitude, slowed the activation kinetic and induced a leftward shift of the 
activation curve. On the contrary, chronic EPA did not modified Kv7.1/KCNE1 current and shifted the activation 
curve towards the opposite direction. In addition, chronic EPA decreased the expression of Kv7.1 but not of 
KCNE1, and induced a wider distribution of Kv7.1 over the cell membrane. Experiments with methyl-β-
cyclodextrin demonstrated that removal of cholesterol increased the Kv7.1 current magnitude. In cholesterol 
depleted cells, EPA produces similar effects than those produced acutely that could be reverted after wash-out 
with drug-free external solution, suggesting a direct effect on the channel. Mutations involving cardiac ion 
channels result in abnormal action potential (AP) formation or propagation, leading to cardiac arrhythmias. They 
constitute approximately 10–20% of all sudden cardiac death (SCD). The short QT syndrome is a new congenital 
entity characterized by a shortened QTc interval in the ECG and a lack of adaptation during increasing heart 
rates. In the present Doctoral Thesis, we used the patch-clamp technique to characterize the novel F279I Kv7.1 
mutation found on a 23 years old man with a QTc of 356 ms and a familial history of SCD. In the absence of 
KCNE1, WT and F279I Kv7.1 currents had similar biophysical properties. However, functional analysis of F279I 
Kv7.1 (alone or co-expressed with the WT channel, in the presence of KCNE1) revealed a pronounced shift of the 
half-activation potential and an acceleration of the activation kinetics leading to a gain of function in IKs. We 
conclude that the F279I mutation would predict to augment substantially repolarizing current during the AP due to 
an impaired coupling of the Kv7.1 gating modulation induced by KCNE1. 
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1.1 ION CHANNELS 
 
Ion channels are part of the mechanism of cellular signaling of almost all live cells. Our ability to do 
gymnastic, to perceive a colorful world and to process language relies on rapid communication among cells. 
Such signaling, the fastest in our bodies, involves electrical fluxes produced when ion channels open and close. 
Fast electrical signaling is made possible by the homeostatic mechanisms that establish the standard 
environment and content of animal cells: high Na+ concentration [Na+] in the blood and extracellular fluid, and 
high [K+] (but low [Na+] and [Ca2+]) in the cytoplasm. Gradients are established and maintained by active 
transporters and pumps, which prepare the way for rapid changes in membrane voltage to be produced by 
passive transport through ion channels. These pore-forming proteins allow ions to flow only “downhill”, as 
dictated by their electrochemical gradients, but they do it rapidly (the rate of passage of ions through one open 
channel is often more than 106 ions per second) and selectively. Opening a Na+ or Ca2+ selective channel 
permits Na+ or Ca2+ to flow down its gradient into a cell, making the intracellular voltage more positive. Opening 
a K+ selective channel permits K+ to flow from the cell and restores the voltage to a negative value. The 
dimensions of a typical cell and its membrane allow the voltage to be changed rapidly back and forth many 
times, with relatively small changes in concentration. This is essentially how all cellular electrical signaling is 
produced (2). 
 
1.2 CLASSIFICATION OF POTASSIUM CHANNELS 
 
Voltage-gated ion channel protein superfamily, formed by more than 140 members, is one of the largest 
groups of signal transduction proteins (3,4). Among them, potassium channels are the largest and most diverse 
family of ion channels. The first K+ channel to be identified came from the cloning of the Shaker gene of 
Drosophila which causes flies to shake when exposed to ether (5). However, ion channels are found in bacterial, 
archeal, and eukaryotic cells both plant and animal and their amino acid sequences are very easy to recognize 
because K+ channels contain a highly conserved segment called the potassium signature sequence (GYG) (6). 
This sequence forms a structural element known as the selectivity filter, which prevents the passage of sodium 
ions but allows potassium ions through the ion channel pore at rates approaching the diffusion limit. Diversity 
among different members of the K+ channel family is related mainly to the various ways in which K+ channels are 
gated. Some K+ channels are ligand gated, which means that pore opening is energetically coupled to the 
binding of an ion (7), a small organic molecule, or even in some cases a protein (8). Other K+ channels are 
voltage-gated, in which case pore opening is energetically coupled to the movement of a charged voltage-sensor 
within the membrane electric field (9,10). Based on their molecular architecture, different channel classes are 
distinguished (Figure 1) (11-14). The simplest structural type of K+ channels is visible in the 2TM/1P class, 
named after their typical composition of two transmembrane helices (TM) and one P-loop (P), and is represented 
by the inward rectifier K+ channels (Kir). The second group is referred to as voltage-gated K+ channels (Kv). They 
are composed of six TM helices (S1-S6) and one P-loop, resulting in the 6TM/1P class. The two-P K+ channels 
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family is constituted by the non voltage-gated outward rectifier channels that have an eight TM architecture that 
contains two P-regions per subunit (8TM/2P) and the class of the so-called “background” or “leakage” channels 
made up of two P-regions, hence structurally referred to as 4TM/2P type (15,16). 
 
1.3 VOLTAGE-GATED POTASSIUM CHANNELS 
 
Voltage-gated K+ channels (Kv) “sense’’ voltage differences across the cell membrane and open or 
close in response to changes in the membrane potential. To date, twelve different subfamilies of Kv channels 
subunits have been described (Kv1-12) (17,18). Kv channels are formed by co-assembly of four α subunits, each 
containing six α-helical TM segments (S1-S6), with both N- and C-termini on the intracellular side of the 
membrane. Each subunit comprises two membrane-integrated functionally distinct modules; one forms the 
voltage-sensor (S1-S4) and the other the K+ selective pore with the gate (S5-P-S6) (Figure 2A).  
The N-terminus of Kv1-4 channels contains a “tetramerization domain” (T1 domain) (Figure 2B). It 
determines the specificity of channel subunit assembly and also serves as a platform for binding of auxiliary Kv 
cytoplasmic β-subunits. The cytoplasmic C-terminus of Shaker K+ channels has no obvious domain structure. By 
Figure 1. The four main classes of potassium channels. (A) 2TM/P channels, which consist of two 
transmembrane (TM) helices with a P loop between them, exemplified by inwardly rectifying K+ channels and by 
bacterial K+ channels such as KcsA. (B) 6TM/P channels, which are the predominant class among ligand-gated and 
voltage-gated K+ channels. (C) 8TM/2P channels, which are hybrids of 6TM/P and 2TM/P, and were first found in 
yeast. (D) 4TM/2P channels, which consist of two repeats of 2TM/P channels. 8TM/2P and 4TM/2P probably 
assemble as dimers to form a channel. 4TM/2P channels are far more common than was originally thought. These 
so called ‘leakage’ channels are targets of numerous anaesthetics. S4 is marked with plus signs to indicate its role in 
voltage sensing in the voltage-gated K+ channels. Taken from Choe et al 2002 (3). 
 
Introduction 
 5 
contrast, other Kv channels are characterized by the presence of a subunit assembly domain and/or a sensor 
domain in the C terminus. These include Kv7 and Kv10-12 channels, as well as potassium channels gated by 
voltage and intracellular Ca2+ (e.g. KCa1 channels) and channels gated exclusively by intracellular ligands like 
Ca2+ (e.g. KCa2 channels) (Figure 2C). The auxiliary subunits known to be associated with this family (KCNE, 
β1- β4) are transmembrane proteins; they appear to be intimately associated with the pore domain and may 
displace the voltage-sensor domain or interact with it directly (19,20). 
 
1.3.1 Ion pore and selectivity filter of Kv channels 
 
The essential role of all K+ channels is to conduct K+ ions across the cell membrane. The atomic 
radius of K+ is 1.33 Å and that of Na+ is 0.95 Å. With only this difference in ionic radius to work with, K+ channels 
manage to select for the K+ ion over the Na+ ion by a factor of more than 1000. Moreover, this strong selectivity 
for K+ is achieved without compromising the rates of conduction, which approach the diffusion limit. The K+ 
channel pore is comprised of four usually identical subunits that encircle with four-fold symmetry a central ion 
Figure 2. Summary of structural components of Kv channels. (A) Schematic representation of the tetrameric
organization of a Kv channel. A structural folding model of one of the four  subunits is shown on the right. (B)
General organization of the Kv1–Kv4 channels group with the T1 “tetramerization domains” hanging centrally below
the transmembranal core and attached to it through four linkers continued from the first transmembrane helices. In
this case, the C-terminus structures probably track to the periphery surrounding T1 and extending to its bottom. (C)
General architecture of the Kv7 and Kv10–Kv12 channels characterized by a C-terminus (i.e., the C-linker/cyclic
nucleotide-binding domain (CNBD) region of the Kv10–Kv12 channels or the A–D helical regions of the Kv7 channels)
forming a compact tetrameric structure in a central position immediately below the cytoplasmic pore opening. In this
case the N-terminus probably surrounds the C-terminus and extends to its bottom establishing extensive contacts
with its top and side surfaces. Note that in both models the initial N-termini structures are likely to interact with the
gate surroundings in the transmembrane core. S4 segment is also depicted as a reference. Adapted from Barros
and de la Peña 2012(19) 
 
A B
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conduction pathway (21,22). The first K+ to be crystallized was the bacterial KcsA channel.Two of the four 
subunits of the KcsA are shown in Figure 3. Each subunit contains two fully transmembrane α-helices termed 
inner (nearest the ion pathway) and outer (nearest the membrane) helices (equivalent to S5 and S6 of Kv 
channels), and a tilted pore helix that runs half way through the membrane, pointing its C-terminus negative 
charge toward the ion pathway. Near the midpoint of the membrane, the ion pathway is nearly 10 Å in diameter, 
forming a central water-filled cavity. A hydrated K+ ion remains suspended at the center of the cavity in the 
crystal structure (23). 
Potassium selectivity is determined by the selectivity filter, located in the extracellular third of the ion 
pathway in between the central cavity and the extracellular solution. The K+ channel signature sequence amino 
acids (GYG), conserved in K+ channels throughout the phylogeny, form the selectivity filter. Here, conducting K+ 
ions encounter four evenly spaced layers of carbonyl oxygen atoms and a single layer of threonine hydroxyl 
oxygen atoms, which create four K+ ion binding sites numbered 1 to 4 from the extracellular to the intracellular 
side. At these sites, K+ ions bind in an essentially dehydrated state, surrounded by eight oxygen atoms from the 
protein, four ‘above’ and four ‘below’ each ion. The arrangement of protein oxygen atoms surrounding each 
binding site in the selectivity filter is very similar to the arrangement of water molecules around the hydrated K+ 
ion observed in the central cavity. Thus, the crystal structure provides an explicit demonstration of the selectivity  
 
filter’s role, to create a queue of K+ binding sites that mimic the waters of hydration surrounding a K+ ion. 
Potassium ions are therefore able to diffuse from water into the selectivity filter where the energetic cost of 
dehydration is compensated. Sodium ions, on the other hand, do not seem to enter the selectivity filter in crystal 
structures even when Na+ is present in vast excess (22,24). In fact, reduction of K+ to 3 mM in the presence of 
150 mM Na+ causes the selectivity filter to undergo a conformational change to a ‘collapsed’ state. The structure 
of Kv channels differs from that of the non-voltage-gated bacterial potassium channel KcsA due to a sharp-bend 
in the S6 helices (equivalent to the inner helices of the KcsA channel). This bend occur at a Pro-X-Pro sequence 
that is absolutely conserved in the Kv channels (25). 
 
1.3.2 Voltage-sensor of Kv channels  
 
For Kv channels the membrane voltage determines whether they are open and therefore, they provide a 
A B Figure 3. The ion conduction pore of K+ channels.(A): Two of the four subunits from the KcsA pore are 
shown with the extracellular side on top. Each subunit 
contains an outer helix close to the membrane, an inner 
helix close to the pore, a pore helix (red) and a selectivity 
filter (gold). Blue mesh shows electron density for K+
ions and water along the pore. (B) Close-up view of the 
selectivity filter with dehydrated K+ ions at positions 1 
through 4 (external to internal) inside the filter and a
hydrated K+ ion in the central cavity below the filter. 
Taken from Mackinnon 2003 (22) 
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way for the membrane voltage to feed back onto itself, a key property for generating electrical impulses (26). 
Different reports have revealed that the S1-S4 region acts as the voltage-sensor of Kv channels (27) (Figure 4). 
The S4 segment (which exhibits seven positively charged residues) is the major component of the -sensor for 
gating, although negative charges in S1, S2 and S3 also contribute to this process. S3 is actually formed by two 
helices referred to as S3a and S3b (Figure 4C). In all of the crystal structures determined, S3b forms with S4 a 
helix-turn-helix structure called the voltage-sensor paddle (28,29). Depolarization of the cell membrane causes a 
physical outward movement of S4, which induces further conformational changes that open the channel pore 
and permit selective K+ permeation. This movement has been monitored electrically as the gating current 
(29,30), or by means of fluorescence (30,31). 
 
1.3.3 Coupling of voltage sensing to gating of Kv channels 
 
The gate region in K+ channels controls whether K+ ions can traverse the ion conduction pore. 
Comparison of the structural data from K+ channels trapped in the open conformation, MthK, KvAP and Kv1.2 
Figure 4. Schematic view of the voltage-sensor of K+ channels. (A) Ribbon representation of the
transmembrane region of Kv2.1 paddle–Kv1.2 chimera channel tetramer (Kvchim, viewed from the side, and
oriented with the extracellular solution above. The pore is colored blue; the voltage sensor paddle (S3b and S4)
and the linker helix (S4-S5) between voltage sensor and the pore red; and S1, S2, and S3a gray. The voltage
sensor closest to the viewer was removed for clarity. K+ ions in the selectivity filter are shown as green spheres.
(B) Ribbon representation of the pore and S4-S5 linkers in the hypothetical closed conformation (C) from a model
constructed from the Kvchim and KcsA structures and in the open conformation (O) from the crystal structure of
Kvchim. In the hypothetical closed state, based on the closed conformation of KcsA, the S4-S5 linker helices are
pushed down to maintain their same contacts with the pore. (C) View of the voltage sensor and S4-S5 linker helix
of the open conformation from Kvchim. Side chains of the positively charged residues on S4 (labeled as R0, R1,
R2, R3, R4, and K5) and the negatively charged residues forming ionizing hydrogen bonds (dashed black lines)
with the positive charges, as well as those of the three residues (labeled F, E, and D) forming an occluded binding
site in the voltage sensor, are shown as sticks and colored according to atom types (yellow, carbon; blue,
nitrogen; red, oxygen; and green, phenylalanine). Taken from Tao et al 2010 (30). 
 
A
B
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(28,32-35), and channels trapped in the closed conformation, KcsA and KirBac1.1 (21,36), indicates that gate 
opening is associated with a conformational change of the S6 helix. Bending of the S6 helix at a glycine hinge 
may well explain gating in bacterial K+ channels. However, the S6 helix of many eukaryotic Kv channels has a 
PVP motif. Results of accessibility studies (25,37-40) suggest that opening of the S6 bundle takes place at the 
PVP motif of Kv1 channels. The crystal structure of the rat Kv1.2 (28,35) supports this view and shows that 
widening of the S6 occurs because of a bend at the PVP motif. Apparently, opening of the gate is associated 
with the bending of inner TM2/S6 helix which can occur at either a glycine or a PVP motif. It is not well 
understood how motion of the voltage-sensor couples to the channel opening. Several studies on Shaker and 
related channels suggest the S4-S5 linker and the end of S6 are involved in coupling (41-48). The crystal 
structure of Kv1.2 demonstrates this interaction clearly. The distal end of the S4-S5 linker comes close to the 
internal end of S5 below the PVP motif, with extensive contacts between side chains of the two regions. This 
structural picture of the activated conformation suggests that to close the gate, the S4-S5 linker would have to 
move inward, shutting down the S6 gate (28,35). As discussed above, the S4-S5 linker and C-terminus end of 
S6 are critical for coupling between voltage-sensor movement and channel opening. In addition, studies on a 
triple mutant of Shaker (named ILT) where three positions in S4 were mutated to the corresponding residues in 
Shaw (49,50), revealed that in ILT, the voltage ranges over which the voltage-sensor movement and the channel 
opening occur were quite well separated. It is suggested that S4 itself plays a role in coupling voltage sensing 
with gating (51). The effect of the ILT mutations was proposed to be due to interactions between a hydrophobic 
face of S4 and the neighbouring subunit’s S5, which is consistent with the crystal structure of Kv1.2 (28,35). 
 
1.3.4 Characteristics of Kv channels  
 
A brief description of the electrophysiological properties of Kv channels studied in the present Doctoral 
Thesis is given in this section. 
 
1.3.4.1 Kv1.3 channels 
 
Kv1.3 channel was first cloned in rat and mouse brain, where it was named RCK3 (52), KV3 (53) or 
RGK5 (54) and MK3 (55) respectively. In addition, this channel was also cloned from mouse (56), rat (57) and 
finally from human T lymphocytes and was identified as HLK3, HGK5 (57,58). The channel gating characteristics 
and the distinctive pharmacological profile provided unique biophysical fingerprint that enabled to identify all 
these clones as Kv1.3 with the standardized nomenclature. Kv1.3 channels expressed in olfactory bulb neurons 
are involved in the mechanism of signal transduction (59,60). These proteins also participate in the translocation 
of the glucose transporters, GLUT4, to the plasma membrane in adipocytes, suggesting that ion channels are 
important in insulin sensitivity (59,61,62). In the immune response, Kv1.3 channels play a crucial role in the 
regulation of the resting potential and calcium signaling and thus, in the activation of T lymphocytes and 
macrophages (63-67). In the presence of lipopolysaccharide (LPS), protein levels of these channels increase 
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(63,68,69). Kv1.3 selective blockers have been used in the treatment of autoimmune diseases. The activation 
threshold for Kv1.3 channels is ~ -50 mV, and the midpoint for the activation curve is  -33 mV. Kv1.3 current 
activates with an exponential time course (act <10 ms). After depolarization to + 60 mV, the current reaches the 
maximum peak amplitude and then, C-type inactivation proceeds with a time constant of 200–400 ms (Figure 5 
top panel) (70,71). C-type inactivation occurs by a conformational change at the external side of the channel 
pore (60,72-74), and results in use-dependent or cumulative inactivation during repeated episodes of 
depolarization (Figure 5 low panel) (73,75). Interaction studies between Kv1.3 and auxiliary β subunits are 
scarce. It was shown that T lymphocytes, in which Kv1.3 channels are the major contributors to Kv current, 
Kvβ1.1 and Kvβ2.1 are also expressed (76). The expression of these modulator subunits is also increased after 
stimulating lymphocyte with proliferative cytokine interleukin 2 (IL2). Also, all splice variants of the Kvβ1.1 gene 
(Kvβ1.1, Kvβ1.2, and Kvβ1.3) were detected in these cells, as well as the only Kvβ2 gene product described to 
date (Kvβ2.1) (77). This study suggested that differential Kvβ expression modifies the electrical properties of Kv 
current in macrophages, and that this modulation is dependent on proliferation and the mode of activation of 
immune cells. Kv1.3 channel has different target sequences susceptible to be phosphorilated by protein kinase C 
(PKC). However, several reports demonstrated that phosphorylation at these positions did not modify the 
physiological current properties (78,79). It has been described that Kv1.3 channels are regulated by PKA in 
human T lymphocytes, being this effect mediated by LcK and Dlg1 (78,80). Blockers of Kv1.3 channels belong to 
two large classes: peptide toxins and small molecule blockers. Kv1.3 blocking toxins from scorpions, sea 
anemones or other animals such as charybdotoxin and margatoxin carry a large positive net charge and 
consequently are impermeant through cell membranes. Peptide toxins utilize a “cork in the bottle” blocking 
strategy, covering and plugging the external end of the channel pore, thereby preventing the efflux of K+ ions 
(81-83). In contrast, small molecule blockers including correolide are hydrophobic and thus, easily permeate 
through cell membranes. They bind from the intracellular side to the internal end of the selectivity filter. Due to 
their smaller size, these molecules have fewer contact points with the channel than peptide toxins, which 
generally results in lower affinity and poorer selectivity (84-86). A notable exception to the typical small molecule 
behaviour is the membrane impermeant K+ channel blocker tetraethylammonium (TEA), which is capable of 
blocking the channel from both sides. 
 
1.3.4.2 Kv1.5 channels 
 
Kv1.5 channel was first cloned from human ventricle (87) and then from atrium (88). It is highly 
homologous with the Shaker K+ channel in Drosophila (5). In the heart, Kv1.5 channels generate the IKur current. 
Despite mRNA and protein expression of Kv1.5 in both atria and ventricles (89), IKur is confined to atrial myocytes 
and virtually absent in ventricular myocytes of most species. Kv1.5 channels are also expressed in many other 
organs, including pulmonary arteries (90), skeletal muscle (91), rat brain (53), and immune cells (92). Kv1.5 are 
also involved in the maintenance of vascular smooth muscle tone, glucose-stimulated insulin release by β-
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pancreatic cell, cell volume regulation and cell growth (15). Heterologous expression of Kv1.5 results in a robust 
outward current with a midpoint for activation potential of 0 mV (Figure 5). At room temperature, current 
activates rapidly at potentials between 0 and +60 mV (act <10 ms) and inactivates only partially, i.e. by 10-20% 
after 250 ms at +60 mV. Inactivation follows a bi-exponential time course with time constants of 240 and 2700 
ms (93,94). Kv1.5 channels display outward rectification and very slow inactivation during strong depolarizations 
(Figure 5). Inactivation is temperature dependent and accelerates at more physiological temperature (95-97). 
The electrophysiological properties of Kv1.5 are modified by the assembly of Kvβ subunits (Kvβ1.2, Kvβ1.3, and 
Kvβ2.1) (98,99). The Kvβ1.3 subunit provides a number of functions, including a fast and partial inactivation  
 
component, that is mediated by an equilibrium binding of the N-terminus of Kvβ1.3 between PIPs and the inner 
pore region of the channel which overlaps with the Kvβ1.3 binding site (100), a greater degree of slow 
inactivation, a shift of the activation curve toward more negative potentials, a 7-fold decrease in the sensitivity of 
the channel to the block induced by antiarrhythmic drugs and local anaesthetics, and a decrease in the degree of 
stereoselective blockade (100-104). In addition, interaction of Kvβ subunits with Kv1.5 controls channel trafficking 
to the plasma membrane. Although the major groups of ancillary subunits that associate with Kv1.5 channels are 
Kvβ subunits, KChIP2 also modifies channel properties (105). Kv1.5 channels are highly susceptible to 
adrenergic regulation, which is differentially modulated by α and β stimulation (106) via PKC and protein kinase 
A (PKA), respectively (107-109). PKC and PKA activities are also required for the Kv1.5 modulation by the 
auxiliary subunits Kvβ1.2 and Kvβ1.3. (107,108,110). Moreover, it has been described that in rat ventricle, Kv1.5 
associates with Kvβ1.3, various PKC isoforms and other proteins forming a “channelosome” which is a novel 
mechanism for signal transduction (111). Channels are also regulated by nitric oxide (NO) via a cyclic guanosine 
monophosphate/Protein kinase G (cGMP/PKG) dependent pathway. NO donors decrease Kv1.5 in an 
expression system (112). Based on molecular modelling, these authors showed that S-nitrosylation of two 
cystein residues in S2 (Cys331 and Cys 346) are involved in this effect. The current is sensitive to most class I 
 
 
Figure 5: Electrophysiological characteristics of 
Kv1.3 and Kv1.5 channels. Top panel shows Kv1.3 
and Kv1.5 current traces recorded using the protocol 
shown on the top in Ltk- and HEK293 heterologous 
expression systems. Adapted from Tang et al 2007 
(70) and Macias et al 2010 (92) respectively). At the 
end of the depolarizing pulse, the degree of 
inactivation is greater for Kv1.3 channels Bottom 
panel shows the use dependence of Kv1.5 and 
Kv1.3 channels after applying a train of depolarizing 
pulses at 1 Hz. Adapted from Fadool et al 2004 (59) 
and Valenzuela et al 1996 (93) Respectively. The 
different electrophysiological properties of these 
channels allow to differentiate the composition of Kv 
channels in the cell membrane when various types 
of K+ channels are expressed. 
 
 
 
Kv1.3 Kv1.5
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antiarrhythmic drugs and local anesthetics (94,113-116), to low concentrations of 4-aminopyridine (4-AP), but is 
rather insensitive to (TEA) (97)or dendrodotoxin (117). Most of these compounds are open channel blockers that 
bind to a common internal receptor site at Kv1.5 channels.  
 
1.3.4.3 Kv7.1 channels 
 
The KCNQ1 gene was first identified by Wang and colleagues (118) in a linkage study of patients with 
long QT interval syndrome type 1. Its gene product, Kv7.1 (also termed KvLQT1 or KCNQ1), is a voltage-gated 
K+ channel α-subunit, and its expression was detected in several mammalian tissues, including heart, epithelia, 
lung, stomach, adrenal and thyroid glands, kidney, pancreas, small intestine and inner ear (119,120). The other 
four Kv7 channels (Kv7.2-7.5) from the Kv7 family are highly expressed in the central and peripheral nervous 
system. Kv7 channels exhibit, as a distinctive feature, a C-terminal domain much longer than that of other Kv 
channels,. It contains several structural motifs including coiled-coils, calmodulin-binding structures, and basic 
aminoacid clusters, which are critical for Kv7 assembly and trafficking, and also gating (Figure 6B). Kv7.1 
channels expressed in heterologous systems generate a classical delayed rectifier potassium-selective channel 
with fast activation kinetics (act <100 ms at +60 mV) and relatively slow deactivation. The midpoint for the 
activation curve of Kv7.1 channels is  -23 mV. Upon long depolarizing steps, a fraction of Kv7.1 channels 
undergo partial inactivation (121-123). The inactivated current component can be visualized upon repolarization 
as a hook on the current trace, since the Kv7.1 channel has to go to the open state from the inactivated one 
before it closes (deactivates) (Figure 6A top). This inactivation property of Kv7.1 channels is determined by the 
S5 transmembrane domain and the P-loop, and changes of just a single residue in this area can abolish the 
inactivation (124,125). Kv7.1 channels have a small single-channel conductance ranging from 2 to 8 pS, 
depending on the composition of the intra- and extracellular recording solution (121,126-128). Kv7.1 channels 
are selectively blocked by chromanol 293B (129), azilamide (130) and IKs124 (131), but almost insensitive to 
TEA (132) and 4A-P (133). The extensive versatility of Kv7.1 channel function is widely due to the channel ability 
to interact with ancillary subunits from the KCNE family. Kv7.1 channels associate with all five members of the 
KCNE β-subunit family to fulfil a variety of physiological functions.  
The cardiac repolarizing potassium current, consists of two major components, the rapid delayed 
rectifier potassium current (IKr) and the slow delayed rectifier potassium current (IKs) (134). Kv7.1 co-assembles 
with the KCNE1 beta subunit to form the channel complex that mediates IKs (135,136). Although KCNE1 is the 
major accessory subunit assembling with Kv7.1 in the heart, other subunits of the KCNE family might be present 
(137), serving as additional regulators of IKs (138). The significance of Kv7.1 and its accessory beta subunits for 
maintaining normal rhythmicity is further emphasized by the numerous Kv7.1 and KCNE mutations associated 
with cardiac arrhythmias. Some of these mutations can lead to a loss of channel function causing long QT 
syndrome, a disorder predisposing affected individuals to Torsade de Pointes arrhythmia and sudden cardiac 
death (SCD). The presence of KCNE1 drastically modifies Kv7.1 activity by increasing unitary conductance as 
well as macroscopic currents, slowing activation, right-shifting voltage dependence of activation, suppressing 
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currents at low activating voltages, suppressing partial inactivation, and modulating its pharmacology 
(121,124,125,127,135,136,139-145). Kv7.1/KCNE1 complexes open at potentials positive to -20 mV and give 
rise to currents with very slow activation kinetics (Figure 6A bottom). The increased current level compared with 
that of homomeric Kv7.1 channels is caused both by an increase in the single-channel conductance 
(121,127,128) and by a loss of the inactivation state. Seebohm and colleagues (124) found that co-expression of 
KCNE1 stabilizes the open conformation of the Kv7.1 pore by altering an interaction between the pore helix, the 
selectivity filter, and the S5-P-S6 domain.  
It is known for many years that the cardiac IKs is upregulated following sympathetic stimulation (146). 
This upregulation of the Kv7.1/KCNE1 current is mediated by β-adrenergic receptor activation, leading to an 
increased level of cyclic adenosine monophosphate (cAMP) and thereby PKA stimulation, which interacts with 
the IKs complex through an A-kinase anchoring protein 9 (AKAP9) (Figure 6B) (147). Kass and co-workers 
showed that PKA and protein phosphatase 1 interact with Kv7.1 through the AKAP9, called yotiao, which binds 
to the C-terminus tail of Kv7.1 via a leucine zipper motif (148). Upon PKA activation, residue S27 in the N-
terminus of Kv7 is phosphorylated. However, yotiao seems not only to be important for mediating the 
phosphorylation of S27, but it is also necessary to transform the phosphorylated Kv7.1 subunit into a channel 
with altered activity (149). The cAMP-mediated regulation of Kv7.1 channels in mammalian expression systems 
is dependent on co-expression of KCNE1 and, indeed, mutations described in both Kv7.1 and KCNE1 identified 
in long QT syndrome patients have been found to disrupt this regulation (148,149). PIP2 is another key 
Figure 6. Electrophysiological characteristic of Kv7.1 and Kv7.1/KCNE1 channels and schematic 
representation of the C-terminus tail structures of Kv7 channels. Left panel (A) shows Kv7.1 and Kv7.1/KNCE1 
current traces recorded using the protocol shown on the top expressed in COS7 cells (B). The four helical regions 
(helices A–D) are shown as cylinders. Formation of coiled-coil assemblies at the level of helices C and D is indicated. 
The proposed location of the conserved interaction sites with calmodulin (CaM) and phosphatidylinositol 4,5-
bisphosphate (PIP2), with A-kinase anchoring protein 79/150 (AKAP79/150) in Kv7.2, with the auxiliary β subunit 
KCNE1 in Kv7.1, with AKAP-Yotiao in Kv7.1, with ankyrin-G in Kv7.2–Kv7.3 and with ubiquitin-protein ligase Nedd4-2 
in Kv7.1 and Kv7.2–Kv7.3, are also shown. Phosphorylation sites by Src kinase in helix A and by protein kinase C in 
helix B are indicated by an encircled P. Adapted from Barros and de la Peña 2012 (19). 
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intracellular regulator of the Kv7.1/KCNE1 channel activity (150). PIP2 affects the Kv7.1/KCNE1 channel by 
stabilizing the open state, resulting in increased amplitude, which can be sustained if Mg-ATP is present. 
Furthermore, PIP2 slows the deactivation kinetics and shifts the activation curve. The importance of this 
interaction, occurring primarily with residues in the very proximal C-terminus, is emphasized by the fact that 
reduced PIP2 affinity of Kv7.1 mutants found in long QT syndrome patients may underlie this pathology (151). 
 
1.4 INWARD RECTIFYING POTASSIUM CHANNELS 
 
Since the initial cDNA cloning of the first inward rectifiers Kir1.1 (ROMK1) and Kir2.1 (IRK1) in 1993 
(152,153), a succession of new members of this family have been discovered. To date, around twenty members, 
including the G protein-coupled Kir3 and the ATP-sensitive Kir6 of this superfamily have been cloned. Kir 
channels can be grouped into seven families by sequence similarity, and designated Kir1-7 (154,155). These 
channels play an important physiological role in the function of many organs, including brain, heart, kidney, 
endocrine cells, ears, retina, and immune cells, such as T lymphocytes and macrophages (156).  
The N- and C- terminus of Kir subunits are exposed to the cytoplasm and associate with each other to 
form a cytoplasmic domain that is linked to, but distinct from the transmembrane domain. The transmembrane 
domain is mainly responsible for ion selectivity and gating. The cytoplasmic domain is thought to act as a gating 
modulator (156). Like Kv channels, Kir channels exhibit the K+ channel signature (TXGY(F)G) that constitutes the 
selectivity filter in the transmembrane domain. The four groups of associated N- and C-terminus make up a 
cylinder that surrounds the so called cytoplasmic pore. This architecture is a characteristic of the Kir channels 
and extend the ion conduction pathway by ~30 Å. Therefore, in Kir channels, K+ has to pass over 60 Å through 
the pore composed by the cytoplasmic and transmembrane domain (Figure 7A). 
A brief description of the electrophysiological properties of the Kir channel studied in the present 
Doctoral Thesis is given in the following section. 
 
1.4.1 Kir2.1 channels 
 
Kir2 is the principal class of 2TM/1P domain potassium channels. The first member of this family to be 
cloned was from a mouse macrophage cell line and named IRK1/Kir2.1/KCNJ2 (153). Immunolocalization 
studies have revealed it to be present on many cell types within the forebrain, including neurones, microglia, 
endothelial, heart, ependymal and vascular smooth muscle cells (153,157,158). Cloned Kir 2 channel cDNAs 
encode proteins of 370-500 residues. Kir2.1 channel alpha subunits possess only 2TM domains linked with a P-
domain. Thus, Kir2.1 channels share similarity with the fifth and sixth domains, and P-loop of the other families. 
Initially, Kir2.1 subunits were thought to be made up of only homomeric complexes (159). However, recent 
studies have revealed that Kir2.1 subunits can function as heterotetramers both in vitro and in vivo. Indeed, in 
vitro electrophysiological experiments have shown that Kir2.1, Kir2.2, and Kir2.3 can assemble with any one of the 
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other subunits, and the respective heteromer exhibits different properties from that of their homomers (160). The 
channels of this family are constitutively active and exhibit strong inward rectification (which is described as the 
ability to allow large inward currents and smaller outward currents) (Figure 7B) (161). Inward rectification is 
caused by intracellular Mg2+ (162,163) and polyamines (164). Polyamines block the channel pore when the 
membrane potential is more depolarized than the EK (164). Kir channels are responsible for regulating diverse 
processes including: cellular excitability in heart and brain tissue, vascular tone, heart rate, renal salt flow, and 
insulin release (165). They contribute to the establishment of highly negative resting membrane potential and 
long-lasting action potential plateau in various cells types including cardiac myocytes. Kir2.x channels are 
activated by PIPs that are essential for the normal function of the channel (1,166,167). Kir2.1 current is increased 
by cAMP when the channel is co-expressed with AKAP79 and treated with phosphatase inhibitors (168). In 
addition, it has been suggested that phosphorylation or pH might modulate channel function by affecting channel 
PIP2 interaction (1,169,170). Kir 2.1 is blocked by barium (171), cesium (172) and it is almost insensitive to TEA 
and 4-AP (173,174). 
 
1.5 PHYSIOLOGICAL ROLES OF Kv CHANNELS 
 
1.5.1 The cardiac action potential 
 
The normal behaviour of the heart is determined by the ordered propagation of excitatory stimuli 
resulting in rapid depolarization and slow repolarization, generating action potentials (AP) in individual myocytes. 
At the most generic level, abnormalities of impulse generation, propagation, duration and configuration of 
individual cardiac APs form the basis of disordered cardiac rhythm. These concepts evolved during the twentieth 
century from clinical descriptions of arrhythmia, to descriptions of AP in specific regions of cardiac tissue, and 
Figure 7. Crystal structure of the bacterial KirBac1.1 channel and electrophysiological characteristics of Kir2.1. 
(A) The blue bar represents the position of the lipid membrane. On the right, the main secondary structural elements 
that make up the channel are highlighted: slide helix (purple), outer helix (green) pore helix (blue), inner helix (yellow),
C-terminus domain (red) Taken from Kuo et al 2003 (35). (B) Typical Kir2.1 currents recorded using the protocol shown
on the top after heterologous expression in HEK293 cells. Adapted from Lopez-Izquierdo 2010 (161). 
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then to identification of specific whole-cell and single-channel ionic currents whose integrated activity generates 
these APs. In the past decades, cloning efforts have defined genes whose expression generates specific 
molecular components, including ion channel proteins underlying individual ion currents in cardiac myocytes. K+ 
currents control the repolarization process of the cardiac AP, determine membrane potential, heart rates and 
refractoriness of the myocardium and are important targets for the actions of neurotransmitters, hormones, drugs 
and toxins known to modulate cardiac function (12,175-177).  
The AP of a cardiac myocyte exhibits five distinct phases (Figure 8): phase 0 corresponds to the rapid 
depolarization (or AP upstroke) that ensures the cell reaches the voltage threshold. Phase 1 corresponds to the 
brief, rapid repolarization that is initiated at the end of the AP upstroke and that is interrupted when the cell 
reaches the “plateau level” or phase 2. During the plateau, repolarization progresses slowly; but eventually a 
phase of rapid repolarization, or phase 3, ensures it. Finally, phase 4 is the period between the last 
repolarization and the onset of the subsequent AP. It corresponds to the resting membrane potential  
Phase 0: Action potential upstroke. At rest, the dominant membrane conductance is provided by the 
potassium channels. However, once the cell reaches a threshold level of approximately −65 mV, membrane 
sodium channels open. Hence, at threshold, the membrane rapidly switches from being mostly permeable to K+ 
to being largely permeable to Na+. The sodium current (INa) represents a very large and rapid transition. When 
the conductance to sodium suddenly increases, the large transmembrane gradient of Na+ leads to a rush of ions 
into the cell in the form of an inwardly directed negative sodium current (INa). Thus, the membrane rapidly 
Figure 8. Inward depolarizing and outward repolarizing currents that underlie the atrial and 
ventricular action potential. Inward currents: INa sodium current; ICa,L L-type calcium current; Ito transient 
outward current; IKur ultra rapidly activating delayed rectifier current; IKr and IKs rapidly and slowly activating 
delayed rectifier current; IK1 inward rectifier current; IK,ACh acetylcholine-activated potassium current. Note 
that IKur is present in atria only. Phase 0, rapid depolarization; phase 1, rapid early repolarization phase; 
phase 2, slow repolarization phase (‘plateau’ phase); phase 3, rapid late repolarization phase; phase 4, 
resting membrane potential. Adapted from Ravens and Cerbai 2008 (177). 
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becomes less negative; i.e., it depolarizes, and results in the upstroke, or phase 0 of the action potential. In fact, 
given that during phase 0 the cell is mostly permeable to Na+, the membrane potential becomes transiently 
positive as it moves toward ENa (approximately +40 mV). However, the increase in sodium conductance is very 
brief. After a few milliseconds, the sodium channels enter a nonconductive state. The membrane potential does 
not quite reach the sodium equilibrium potential, but stops at approximately +20 mV and then begins to 
repolarize. 
Phase 1: Rapid repolarization. As shown in Figure 8, for the most part, the end of the action potential 
upstroke is brought about by the inactivation of the sodium channels. During the initial phase of repolarization of 
the AP, potassium channels provide the dominant membrane conductance. Depending on the cardiac region, 
and also the specie, there can be important differences in the ionic currents that are activated at this stage, 
depending on the region of the heart from which the cells originate (and also depending on the animal species 
studied), in most cases the so-called “transient outward current” (Ito) provides most of the repolarizing charge. 
This rapidly activating potassium conductance turns on during the action potential upstroke. When the sodium 
channels enter their nonconductive state, repolarization begins in earnest, with the membrane potential heading 
toward the reversal potential for potassium. Ito inactivates also very rapidly, and its contribution to the repolarizing 
process during phases 2 and 3 of the action potential is smaller than that observed during phase 1. 
Phase 2: Action Potential Plateau. Other voltage dependent membrane channels are also activated by 
cell depolarization, although at a slower rate. Consequently, these channels provide a sizable current only 
several milliseconds after the end of the action potential upstroke. The two dominant currents during the plateau 
phase of the action potential, or phase 2, are the inward calcium current (ICa) (including, the L-type calcium 
current and electrogenic sodium–calcium exchanger), and the delayed rectifier potassium outward current (IK),. 
The potassium current IK includes at least two separate components: a rapid component (IKr) and a slow 
component (IKs). In addition, in atrial myocytes the ultrarapidly delayed rectifying potassium current (IKur) also 
contributes to the repolarization of the AP. Given the concentration gradient for Ca2+, opening of calcium 
channels leads to movement of calcium from the extracellular to the intracellular space (i.e., an inwardly 
directed, depolarizing current). Potassium ions, on the other hand, move in the opposite direction. The end result 
is that, while the calcium channels remain open, repolarization by potassium currents is prevented by the 
presence of calcium current that is moving positive charges into the cell. Thus, during the plateau, the 
membrane potential depends on the balance between inward ICa and outward IK currents. Although in some cells 
(e.g., Purkinje fibers) outward currents dominate and the plateau tends to have a consistently negative slope, in 
other cells there may be an actual slight depolarization before repolarization continues (in a “dome like” shape). 
Phase 3: Final Repolarization. Inactivation of the calcium channels leads to the end of the plateau 
(Figure 8). Only potassium channels remain active; consequently, the membrane potential returns relatively 
rapidly toward EK. The delayed rectifier currents (IKr and IKs) tend to close as the cell repolarizes, and thus the 
inward rectifier current (IK1) predominates. 
Phase 4: Diastolic Potential. In muscle cells, the resting potential remains constant throughout the 
diastolic interval. In these cell types, the inward-rectifier current IK1 remains the dominant conductance at rest 
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and it is largely responsible for setting the resting membrane potential. An additional small background 
conductance, with a more positive equilibrium potential, keeps the resting potential slightly more depolarized 
than the value estimated by the potassium equilibrium potential. Atrial and ventricular myocytes remain at this 
level of potential until a new excitatory stimulus brings the membrane potential to threshold, thus eliciting a new 
active response. 
 
1.5.1.1 Channelopathies: The short QT syndrome 
 
In approximately 10–20% of all sudden deaths, no structural cardiac abnormalities can be identified. 
Important potential causes of sudden cardiac deaths in the absence of heart disease are primary electrical 
diseases. Mutations involving cardiac ion channels result in abnormal AP formation or propagation, leading to 
cardiac arrhythmias. In recent years, major advances have been made in the understanding of the molecular 
substrates of inherited arrhythmogenic diseases. With the contribution of molecular genetics and 
electrophysiological studies, the genetic basis of numerous cardiac diseases such as the long QT syndrome, the 
Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and familial atrial fibrillation have 
been established (178-180) 
The short QT syndrome is a cardiac channelopathy associated with a predisposition to atrial fibrillation 
and SCD. The arrhythmogenic potential of a short QT interval was first suggested by Gussak and colleagues 
(181) in 2000 when they reported an isolated case of sudden cardiac death in a young female, and the presence 
of early onset atrial fibrillation in a separate family. Cardiac workup in both instances revealed structurally normal 
hearts. However, electrocardiography (ECG) was notable for markedly abbreviated QT intervals ranging from 
260 to 280 ms (Bazett corrected QT interval, (QTc), values ranging from 248 to 300 ms) in affected subjects. 
Similar findings were reported few years later in a detailed description of 2 unrelated families with short QT 
intervals who suffered from a high incidence of sudden cardiac death in the absence of structural heart disease 
(182). These initial reports led to the recognition of short QT syndrome as a distinct clinical entity and have been 
followed by numerous additional case reports within the past decade that have furthered our insight into this 
condition. To date, 3 separate genes encoding ion channels present in the cardiomyocyte cell membrane have 
been implicated in the pathogenesis of short QT syndrome, and further genetic culprits are suspected (183-185). 
short QT1 syndrome is caused by gain of function of the Kv11.1 channels (IKr). short QT2 is caused by gain of 
function mutations in the KCNQ1 gene encoding the α subunit of the Kv7.1 channel (IKs) A gain of function in the 
KCNJ2 gene encoding for the inwardly rectifying channel protein Kir2.1 is associated with an accelerated 
repolarizarion process. This short QT is classified it as short QT type 3. The mutations linked to the three forms 
of short QT shorten the AP duration. However, a variation in the T-wave phenotype distinguishes the different 
mutations because of the dissimilar time dependence and voltage rates at which IKr, IKs and IK1 operate. In short 
QT1 and short QT2 syndrome, significant action potential duration abbreviation starts at the level of the plateau, 
but the overall morphology of the action potential remains unchanged (185).  
Until date, three mutations associated with short QT2 have been found; two in the S1 S140G (186), 
V141M (187) and another one in the P-loop of Kv7.1 V307L (184). Functional studies revealed that S140G and 
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V141M mutations resulted in a constitutively activated channel. V307L Kv7.1 exhibited a pronounced shift of the 
half-activation potential and an acceleration of the activation kinetics leading to a gain of function in IKs. 
The diagnostic hallmark of the condition is a short ECG QT interval; however, consensus on an 
appropriate cutoff value and diagnostic criteria sufficient to establish a diagnosis of short QT syndrome are still 
emerging. In fact Gollob and colleagues systematically reviewed the literature for reported cases of short QT 
syndrome to develop diagnostic criteria designed to facilitate accurate clinical recognition of the disorder (188).  
 
1.5.1.2 Role of n-3 PUFAs on the cardiovascular function: modulation of cardiac ion 
channels 
 
Omega-3 (n-3) polyunsaturated fatty acids (PUFAs) are essential nutrients that must be acquired from 
the diet and that are required for normal development and cellular function. n-3 PUFAs are derived from two 
sources. Plant derived n-3 PUFAs such as α-linolenic acid (ALA) [(18:3 n-3)] is found in vegetable oils (such as 
flaxseed, canola, and soy bean oils) and walnuts. Marine n-3 PUFAs include eicosapentaenoic acid (EPA) 
[20:5(n-3)] and docosahexaenoic acid (DHA) [22:6(n-3)], and they are found in oily fish and seafood. After the 
industrial revolution, the dramatic increase in the n-6/n-3 ratio in the diet of the populations of Western countries 
has, at least in part, contributed to the rise in cardiovascular disease (CVD) (189,190). Sinclair et al. described 
the rarity of CVD in Greenland Inuits, who consumed a diet rich in n-3 PUFAs (whale, seal, and fish; (191,192)). 
Since that time, a large amount of evidence from cellular and animal studies (193-195), and from clinical trial 
outcomes (196-199) has suggested that an increased intake of fish oil fatty acids has favourable effects on 
cardiovascular health. Analyses of these trials have concluded that these beneficial effects mainly occur through 
the prevention of SCD, which is often preceded by ventricular arrhythmias, indicating that n-3 PUFAs are 
antiarrhythmic (197,200). However, not all studies have demonstrated the cardioprotective effects on CVD of 
PUFAs consumption. Pro-arrhythmic actions have been described for n-3 PUFAs in animal models during acute 
regional myocardial ischemia (201). Moreover, the recent Alpha OMEGA and OMEGA randomized trials, 
involving patients who had suffered a myocardial infarction, did not show any improvement in the clinical results 
following n-3 PUFAs supplementation (202,203), and even a deleterious effect due to an increased risk of 
cardiac death was reported in men with stable angina (without myocardial infarction) who were advised to eat 
fish (204), or in patients with implantable cardioverter defibrillators. (205). These differences could be explained 
by the fact that a diet rich in fish oil could be pro- or anti-arrhythmic depending on the underlying arrhythmogenic 
mechanism. In any case, the mechanism underlying the pro- or anti-arrhythmic effect after n-3 supplementation 
is thought to be related to the modulation of the cardiac ion channels involved in the genesis and/or maintenance 
of cardiac APs. n-3 PUFAs inhibit INa, IKur, Ito, IKr, ICa, and INCX, and enhanced IKs and IK1 (206-214).  
Regarding the effects of n-3 PUFAs on IKs, Doolan and colleagues (209) demonstrated that acute EPA 
and DHA do not modify the electrophysiological characteristics of Kv7.1 channels. On the contrary, these authors 
observed that DHA, but not EPA, increases the magnitude of the IKs generated after activation Kv7.1/KCNE1 
channels expressed in Xenopus oocytes, and that this effect is mediated by the interaction between DHA and 
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the KCNE1 subunit (209). Another study performed in cardiac myocytes obtained from pigs fed with a diet rich in 
n-3 PUFAs, demonstrated that chronic PUFAs also increases IKs (213). However, the precise molecular 
mechanism by which n-3 PUFAs exert their actions on this and other cardiac ion currents remained to be 
elucidated. 
 
1.5.2 Role of Kv currents in the immune response 
 
Inflammation is a defensive response to trauma or microbial invasions. This response is designed to 
remove the inciting stimulus and resolve tissue damage. On the contrary, excessive inflammatory responses can 
cause local tissue damage and remodeling, which may lead to significant and chronic injury. Therefore, acute 
inflammation in healthy individuals is self-limiting and has an active termination program. Recent studies have 
suggested that low-grade systemic inflammation is one of the characteristics features of obesity, diabetes 
mellitus, cancer, Alzheimer’s disease and several cardiovascular pathologies, such as atherosclerosis, atrial 
fibrillation, myocardial infarction or heart failure, implying that prevention or suppression of inflammation 
decrease the burden of these diseases (215-226). 
Acute inflammatory reaction in response to infection or tissue damage is characterized by the classic 
cardinal signs of inflammation (heat, redness, swelling and pain), and in experimental settings in vivo the 
temporal relationships are well established, e.g. edema and the accumulation of leukocytes, specifically 
polymorphonuclear leukocytes, followed by monocytes and macrophages. These events in self-limited or 
resolving inflammatory reactions are coupled with release of local factors that prevent further or excessive 
trafficking of leukocytes allowing for resolution (227-229). Early in the inflammatory response, pro-inflammatory 
mediators such as prostaglandins and leukotrienes play an important role (230). The progression from acute to 
chronic inflammation is commonly viewed as an excess of pro-inflammatory mediators. Although mononuclear 
cells can sometimes contribute to pro-inflammatory responses, they are also critical in wound healing, tissue 
repair and remodeling (231). Thus, it is highly plausible that defects associated with mounting endogenous 
proresolving circuits and local autacoids could underlie some of the pathologic events in chronic inflammation. 
The complete resolution of an acute inflammatory response and the return of the local tissues to homeostasis 
are necessary for ongoing health. 
Macrophages play an important role in the inflammatory response, acting as professional antigen-
presenting cells and modifying the cytokine milieu and the intensity of T-cell signaling. Therefore, macrophages 
may tune the immune response toward inflammation or tolerance (232,233). The proliferation, activation, and 
resolution or tolerance of immune cells is mainly modulated by membrane transduction of extracellular signals. 
Some of these interactions involve changes in transmembrane ion fluxes that, in turn, modulate the network of 
intracellular signaling (i.e. Ca2+ fluxes (234)). The electrophysiological properties of macrophages change 
depending on their state of functional activation (67). Indeed, changes in membrane potential that occur as a 
consequence of the modulation of ion channels are among the earliest events in macrophage activation 
(235,236). Macrophages can undergo different activation processes depending on the stimuli received 
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(232,237,238). The classic and innate activations, which can be induced by in vitro culture of macrophages with 
interferon gamma (IFN-γ) plus LPS, are associated with high microbicidal activity, proinflammatory cytokine, 
reactive oxygen and nitrogen species production and cellular immunity. The alternative activation, which can be 
mimicked in vitro after culture with IL-4, IL-13, glucocorticoids, immune complexes, or IL-10, is associated with 
phagocytosis, tissue repair, tumour progression and humoral immunity (239,240). 
Consistent data indicate that ion channels play a pivotal role in the regulation of macrophage 
immunomodulatory responses. Ion channels are tightly regulated during proliferation and activation in 
macrophages, and their functional activity is important for cellular responses (63,67,69). The first ion channel 
described in T lymphocytes and macrophages was the voltage-gated Kv1.3 potassium channel, which has a key 
role in the activation pathway and seems to be the most important target to control T cell and macrophage 
activation (65,66). Together with Kv1.3, Kv1.5 and Kir2.1 channels are also expressed in the plasma membrane 
of immune cells and are involved in the maintenance of the membrane potential (Figure 9) (241). The opening of 
Kv1.3 and Kv1.5 channels at voltages exceeding their activation threshold creates a K+ efflux that would increase 
the driving force for calcium influx. Due to the very high electrical resistance of the lymphocyte membrane, the 
opening of a few of these channels is sufficient to regulate the membrane potential (Figure 9). Besides 
potassium channels, Ca2+ release activated Ca2+ channels (CRAC) are also expressed in the immune cells. Two 
proteins, named Orai1 and STIM1 are necessary to generate CRAC current. Orai1 is the pore forming subunit of 
the channel, while STIM1 is the sensor of Ca2+ depletion in the endoplasmic reticulum (ER) lumen (242-245). 
STIM1 is found in the ER membrane with an EF-hand in the ER lumen, while Orai1 is located in the plasma 
membrane mostly as a dimmer (246). Upon store emptying STIM1 senses the drop in Ca2+ concentration and 
relocalizes to puncta closely associated with the plasma membrane. This translocation brings Orai1 dimmers 
together to form tetrameric active CRAC channels that allow the influx of Ca2+. The concerted action of the two 
K+ channels and the CRAC channel achieves a precisely controlled and long lasting Ca2+ signal that is required 
for the execution of the activation pathway. CRAC channels provide the entry route for Ca2+ while tightly 
regulated K+ efflux maintains a permissive membrane potential for the prolonged Ca2+ influx (Figure 9).  
The other plasma membrane potassium channel of immune cells is the Ca2+ activated KCa3.1 (formerly 
called IKCa1, for intermediate conductance Ca2+ activated K+ channel), which is activated when the free 
intracellular Ca2+ concentration rises above about 200 nM (247). Thus, at resting Ca2+ levels in the cytoplasm are 
low and the channel remains silent; however, upon activation the influx of Ca2+ to the cytoplasm due to ICRAC 
activates them allowing K+ efflux through KCa3.1 channels resulting in a negative feedback loop. Ca2+ sensing is 
accomplished by CaM molecules bound to the C-terminus of KCa3.1 subunits (Figure 9) (248).  
Proliferation and innate activation trigger the induction of the Kv outward current and, in a parallel way, a 
decrease of the Kir2.1 current; whereas alternative activation down regulates Kv current (63,67,69). Experimental 
evidence indicates that in macrophages, the major Kv is mainly a heterotetrameric Kv1.3/Kv1.5 channel (63,69). 
Innate activation changes the stoichiometry of these channels increasing the Kv1.3:Kv1.5 ratio, whereas 
alternative activation decreases it (63,69). CRAC channels are also increased upon classical stimulation. 
However, less is known regarding the role of these channels in the resolution phase (63,69). 
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Lipoxins are endogenous eicosanoids released during the resolution phase of inflammation (249-251) 
and they might modulate Kv channel activity. These lipids are mainly generated by transcellular metabolism from 
arachidonic acid (n-6 PUFA) via lipoxygenase (LOX) enzymes (252,253). In addition to LOX-initiated lipoxin 
biosynthesis, another route involving cyclooxygenase 2 (COX-2) has been described. After aspirin ingestion, 
acetylated COX-2 loses the activity required to form prostaglandin, but retains oxygenase activity to produce 
15R-HETE from arachidonate. This intermediate is transformed via 5-LOX in epimeric lipoxins, termed 15-epi-
lipoxins (252). The potent antiinflammatory and proresolving actions of lipoxins and epi-lipoxins have been 
demonstrated in multiple animal models of human diseases (253,254). Both, native lipoxin A4 (LXA4) and 15-epi-
LXA4 (e-LXA4) bind to and activate the lipoxin receptor (ALX) and decrease polymorphonuclear cells infiltration in 
rodent models of acute peritonitis (255). The endogenous protective role of ALX mediating the biological actions 
of lipoxins has been demonstrated in mice overexpressing the human ALX in myeloid cells (256) 
Figure 9. Ion channels in the immune response. Kv1.5, Kv1.3, KCa3.1 Orai 1 and STIM1 is depicted schematically in 
the scheme. In macrophages, three types of K+ channel generate a negative membrane potential (approximately -60 to 
-70 mV) that is required for Ca2+ influx through calcium release-activated calcium (CRAC) channels. Depolarization of 
the cells reduces the driving force for Ca2+ entry, a process that is counteracted by the opening of Kv1.3, Kv1.5 and 
KCa3.1 channels. Kir2.1 channels, by contrast, open in response to Ca2+ influx and increased intracellular Ca2+ 
concentration.  
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Voltage dependent potassium channels are membrane proteins highly modulated by several 
physiological, pharmacological and pathological events (257). Also, Kv channels are involved in a plethora of 
pathophysiological process, including immune response and cardiac arrhythmias. 
In the immune system, it has been described that Kv channels initiate the immune response, in such a 
way that different types of stimulation can increase or decrease the expression of several types of Kv channels in 
macrophages. Indeed, consistent data indicate that Kv channels play a pivotal role in the regulation of 
macrophage immunomodulatory responses: Kv channels are tightly regulated during proliferation and activation in 
macrophages, and their functional activity is important for cellular responses (63,67,69). Proliferation and innate 
activation trigger the induction of the Kv outward current and, in a parallel way, a decrease of the Kir2.1 current; 
whereas alternative activation downregulates Kv current (63,67,69). Experimental evidence indicates that in 
macrophages, the major Kv current is mainly generated by heterotetrameric Kv1.3/Kv1.5 channels (63,69). Innate 
activation changes the stoichiometry of these channels increasing the Kv1.3:Kv1.5 ratio, whereas alternative 
activation decreases it (63,69). However, less is known regarding the role of these channels in the resolution 
phase.  
In the heart, there have been reported hundreds of mutations in several genes encoding Kv and other ion 
channels present in the cell membrane of cardiomyocytes as well as other proteins, such as ankyrin or caveolin, 
which can produce the development of cardiac arrhythmias through different mechanisms. Elucidation of the 
basis of genetic diseases provides unique insights into the mechanisms responsible for the more prevalent 
arrhythmias and sudden cardiac arrest while also permitting the identification of therapeutic opportunities for their 
treatment and prevention. There have been described different mutations in genes that encode potassium 
channels (Kv7.1, Kv11.1) associated with long or short QT syndrome. Mutations in Kv7.1 and Kv11.1 inducing 
short QT syndrome are associated with an increase in outflow of potassium in phase 3 of the cardiac action 
potential. Although the general mechanisms by which the short QT syndrome are known, there are only a few 
cases reported in the literature and the pathogenic role of the short QT syndrome is controversial. The 
electrophysiological study of mutations in genes that encode ion channels allow advanced knowledge of the 
pathophysiology of channelopathies and will be able to explain the differences found in those affected, in 
response to pharmacological agents shedding light on possible therapeutic agents. 80% of the channel mutations 
trigger an abnormal behavior of the channel that is enough to develop cardiac arrhythmias. In addition, an 
increase number of mutations in certain regions of the channels may affect the channel function by modifying 
their interaction with regulatory subunits or impairing traffic and targeting of the complex to specific membrane 
locations. Moreover, some of these mutations can affect the affinity of the channel to different selective blockers 
and modulators (antiarrhythmic drugs, kinases, etc.). 
Finally, Kv channels can be modulated by lipids such as polyunsaturated fatty acids (either PUFAs or 
their metabolites, such as lipoxins). Thus, it has been described that n-3 PUFAs can exert antiarrhythmic actions, 
maybe due to their interaction with cardiac ion channels (206-208,210-212). Lipoxins are endogenous 
eicosanoids released during the resolution phase of inflammation (249-253). They can exert their anti-
inflammatory effects through their initial actions on Kv and Kir channels., and they might modulate Kv channel 
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activity. The potent antiinflammatory and proresolving actions of these lipids have been demonstrated in multiple 
animal models of human diseases (253,254). Both native LXA4 and 15-epi-LXA4 (e-LXA4) (252) bind and activate 
the lipoxin receptor (ALX) and decrease polymorphonuclear cells infiltration in rodent models of acute peritonitis 
(255). The endogenous protective role of ALX mediating the biological actions of lipoxins has been demonstrated 
in mice overexpressing the human ALX in myeloid cells (256). 
The Hypothesis of the present Doctoral Thesis is that Kv channels influence the immune response and 
the cardiac electrophysiology, and that their changes induced by PUFAs or by point-mutations can trigger 
antiarrhythmic/proarrhythmic or anti-inflammatory effects. 
The Main Objective of the present Doctoral Thesis is to analyze the effects of polyunsaturated fatty 
acids on Kv channels in bone marrow derived macrophages and on Kv7.1/KCNE1 channels, as well as to analyze 
the electrophysiological characteristics of a new mutation in the KCNQ1 gene that trigger short QT syndrome. 
In order to achieve this Objective, our specific objectives are to analyze: 
 The electrophysiological effects of 15-epi-LXA4 on Kv and Kir channels in bone marrow derived 
macrophages. 
 The electrophysiological effects of eicosapentaenoic and docohexaenoic acid on Kv7.1/KCNE1 
channels. 
 The electrophysiological characteristics of a new point mutation of the KCNQ1 gene that triggers type 2 
short QT syndrome. 
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3.1. PRIMARY CELL CULTURE  
 
For the treatment of animals and preparation of bone marrow-derived macrophages (BMDM), BALB/c mice 
were housed and bred in our pathogen-free facility, and all experimental procedures were performed following the 
Spanish and European guidelines regarding the use of animals for experimentation. Animals (aged 8 to 12-weeks) 
were sacrificed by CO2 chamber euthanasia. Pelvises, femurs and tibiae were dissected removing adherent 
tissue. The ends of the bones were cut off and the marrow tissue was flushed by irrigation with Dulbecco’s 
Modified Eagle’s Medium (DMEM). The marrow plugs were passed through a 25G needle for dispersion. Bone 
marrow mononuclear phagocytic precursor cells were propagated in suspension by culturing in DMEM containing 
10% fetal bovine serum (FBS), 0.5 µM β-mercaptoethanol, 100 U/ml penicillin, 100 µg/ml streptomycin (all from 
Gibco, Paisley, UK), 1 nM IL-3 (PeproTech, Rocky Hill, NJ, US) and 0.20 nM recombinant murine macrophage 
colony-stimulating factor (M-CSF) (PeproTech,Rocky Hill, NJ, US) in tissue culture plates. The precursor cells 
became adherent within 3 days of culturing. For priming of BMDM, the cells were maintained in RPMI1640 
medium supplemented with 10% Fetal Calf Serum (FCS) for 14 h prior to use. Experiments were carried out in 
phenol-red free RPMI 1640 medium and 1% of heat inactivated FCS plus antibiotics. 
 
3.1.1. COS7 culture 
 
The African green monkey kidney-derived cell line COS7 was obtained from the American Type Culture 
Collection (Rockville, MD, US) and cultured at 37ºC in DMEM supplemented with 10% FCS and antibiotics (100 
IU/ml penicillin and 100 µg/ml streptomycin; all from Gibco, Paisley, UK) in a CO2 humidified atmosphere. The 
culture medium was changed every 2-3 days and briefly trypsinized every 4-5 days. COS7 cells express a 
background K+ current (an endogenous acid-sensitive K+ channel) (258) but its magnitude is too small to interfere 
with the recordings obtained after transfecting the cells with the potassium channels of our interest (Kv7). Even 
more, its biophysical properties widely vary from the transfected ones. These cells do not express endogenously 
the Kv7.1 accessory subunit KCNE1, being a good expression system to study Kv7.x currents. 
 
3.1.1.1 COS7 transfection 
 
For electrophysiological studies of the effects of PUFAs on Kv7.1/KCNE1, COS7 cells were transiently 
transfected with 0.4 µg pcDNA3.1 KCNE1-Kv7.1 concatemer (human KCNE1 linked to the N-terminus of human 
Kv7.1 cDNA, kindly supplied by Dr. Isabelle Baró). In some experiments, 0.5 µg pEYFP-N1-Kv7.1 plus 0.5 µg 
pECFP-C1-KCNE1 (kindly supplied by Dr. Antonio Felipe), were used. In both cases, transfection was performed 
together with 1.6 and 1 µg respectively of the reported plasmid EBO-pcD-Leu2-CD8 (for future selection of the 
transfected cells) per 35 mm culture dish. The total amount of cDNA transfected in both cases was 2 µg. 
For protein expression studies on the effects of PUFAs on Kv7.1 and KCNE1 products, cells were 
transfected with 4 µg pEYFP-N1-Kv7.1 alone or with 4 µg pECFP-C1-KCNE1 per 100 mm culture dish. 
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For electrophysiological studies of the effects of the new mutation F279I in Kv7.1 protein found in the 
clinical practice, the mutation was introduced in the pEYFP-N1-Kv7.1 plasmid by PCR reaction using mutant 
primers and the Quick change site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) following 
manufacturer instructions. COS7 cells were transfected with 1 µg of WT or F279I Kv7.1 constructs and 1 µg 
EBO-pcD-Leu2-CD8 and, for co-expression experiments, 0.5 µg of WT or F279I Kv7.1 constructs plus 0.5 µg 
KCNE1 always in combination with 1 µg EBO-pcD-Leu2-CD8 per 35 mm culture dish. 
In all cases, transient transfections were carried out in COS7 cells at 60-80% confluence following the 
FuGENE6 transfection method (Promega, Southampton, UK). The ratio µg DNA:µl Fugene was 1:3. 
 
3.1.2 HEK293 culture 
 
The Human Embryonic Kidney derived cell line HEK293 was obtained from the American Type Culture 
Collection (Rockville, MD, US) and cultured at 37ºC in DMEM supplemented with 10% FCS and antibiotics (1% 
v/v: penicillin G 10.000 U/mL and streptomycin 10 mg/mL; all from Gibco, Paisley, UK) in a CO2 humidified 
atmosphere. The culture medium of the cell was changed every 2-3 days and briefly trypsinized every 4-5 days.  
 
3.1.2.1 HEK293 transfection 
 
For coimmunoprecipitation and biotinylation assays of WT and F279I Kv7.1 channels, HEK293 cells 
were transiently transfected with 4 µg of WT or mutant Kv7.1 channel plus 4 µg of KCNE1 cDNA per 100 mm 
culture dish using Metafectene Pro (30 µL) at 80% confluence following manufacturer instructions. 24 hours after 
transfection, the cells were ready for use. 
 
3.2 FLOW CYTOMETRY 
 
Apoptosis was detected either with propidium iodide (PI) nuclei staining or with using flow cytometry by 
annexin V binding. Cells were harvested and washed in cold phosphate buffered saline (PBS). After centrifugation 
at 4ºC for 5 min and 1000 × g, cells were resuspended in annexin V binding buffer (10 mM HEPES; pH 7.4, 140 mM 
NaCl, 2.5 mM CaCl2). Cells were labelled with annexin V–FITC solution (BD/Pharmingen, San Jose, CA) and/or PI 
(100 µg/ml) for 15 min at room temperature in the dark. PI is impermeable to living and apoptotic cells but stains 
necrotic and apoptotic dying cells with impaired membrane integrity in contrast to annexin V, which stains early 
apoptotic cells (22). Analysis was carried out using a FC500 Becton Dickinson FACscan flow cytometer (Mountain 
View, CA, USA) using a CXP software (Beckman Coulter, Brea, CA, USA) 
 
3.3 MEASUREMENT OF IKKβ ACTIVITY 
 
To determine the direct effect of e-LXA4 in vitro, IKKβ activity was measured by homogeneous time-
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resolved fluorescence (HTRF) assay, using cloned and expressed IKKβ and biotinylated-IκBα (amino acids 28 to 
40) as substrate. Fluorescence (excitation at 330 nm and emission at 615 and 665 nm) was recorded after 
addition of europium cryptate phospho-Ab recognizing the S32/S36 phosphorylation peptide and streptavidin-  
XL665. Inhibition of IKKβ by staurosporine was used as control (Figure 10). 
 
3.4 IMMUNOCYTOCHEMISTRY OF Kv AND Kir PROTEINS 
 
Cells were seeded into sterile 8-wells chamber slides (Falcon, Lincoln Park, NJ) and activated for the 
indicated time. After fixation with 2% paraformaldehyde for 10 min, cells were then permeabilized in iced 
methanol and incubated with 3% bovine serum albumin (BSA) for 30 min. After incubating with antibodies against 
Kv or Kir at 4ºC for 1 h, cells were washed with PBS followed by incubating with Alexa 488 anti-rabbit secondary 
antibody at 4ºC for 1 h at room temperature (1:500; Molecular Probes, Invitrogen Corporation, Carlsbad, CA, US) 
and Hoechst 33342. Coverslips were mounted in Vectashield (Vector Laboratories, Burlingame, CA) and 
examined using an Espectral Leica TCS SP5 confocal microscope. Values of intensity fluorescence and 
quantification were obtained performed with Image J software (NIH, Bethesda, MD).  
 
3.5 RNA ISOLATION AND RT-PCR ANALYSIS 
 
1 µg of total RNA, extracted with Trizol Reagent (Invitrogen Corporation, Carslbad, CA, US), was reverse 
Figure 10. HTRF interaction assay principle. IκBα–biotinylated substrate for IKKβ, binds to a streptavidin-XL665 
molecule, which is conjugated with a fluorescent acceptor XL665. The phosphorylated substrate can be detected using 
the Anti-Phospho IκBα (Ser32/36) monoclonal antibody coupled to Eu3+ Cryptate fluorescent donor that becomes in 
close proximity to the acceptor and fluoresce transfer is detected. 
 
 
Biotinylated-IκBα
(Tagged substrate)
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reagents
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Anti-Phospho IκBα (Ser32/36)
Ser32/36
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transcribed using Transcriptor First Strand cDNA Synthesis Kit for RT-PCR following the indications of the 
manufacturer (Roche Diagnosis, Manheim, Germany). For priming, a mixture of random hexamers was used to obtain 
a uniform representation of all RNA sequences present in the cellular extracts. Real-time PCR was conducted using 
the SYBR Green method (SYBR® Green PCR Master Mix, Applied Biosystems) on a MyiQ Real-Time PCR System 
(Bio-Rad, Herculaes, CA, US). PCR thermocycling parameters were 95°C for 10 min, 40 cycles of 95°C for 15 s, and 
60°C for 1 min. All samples were analyzed in parallel for 36B4 expression, a ribosomal subunit whose expression is 
not altered under all the conditions tested. Each sample was run in duplicate and was normalized to 36B4. The 
replicates were then averaged, and fold induction (FI) was determined in a ΔΔCt based fold-change calculations. 
 
3.6 PROTEIN EXTRACTION 
 
3.6.1 Protein extraction from BMDM  
 
The BMDM cultures (6-well dishes) were washed twice with ice-cold PBS and the cells were homogenized in 
0.2 ml of buffer A (10 mM Tris-HCl, pH 7.5, 1 mM MgCl2, 1 mM EGTA, 10% glycerol, 0.5% CHAPS, 1 mM β-
mercaptoethanol and 0.1 mM PMSF and a protease inhibitor cocktail (Sigma, St Louis, MO, US). The extracts were 
vortexed for 30 min at 4ºC and centrifuged for 15 min at 13,000 × g. The supernatants were stored at -20ºC.  
 
3.6.2 Protein extraction from COS7 cells 
 
48 hours after transfection, COS7 cells were washed twice in chilled PBS and centrifuged at 3,000 × g 
for 10 min. The pellet was then lysed with ice-cold lysis solution (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1mM 
EDTA, 1% Triton X-100), supplemented with Complete Protease Inhibitor Cocktail Tablets (Roche Diagnostics, 
Mannheim, Germany) by repeated passing (10 times) through a 25G (0.45 × 16 mm) needle. Homogenates were 
further centrifuged at 10,000 × g for 5 min. Samples were separated into aliquots and stored at -20°C.  
All steps were carried out at 4ºC and proteins levels were determined using the Bio-Rad detergent-
compatible protein reagent (Bio-Rad, Herculaes, CA, US). 
 
3.6.3 Protein extraction from HEK293 cells 
 
24 h after transfection, the homogenates were were lysed in immunoprecipitation buffer 1% (50 mM 
HEPES, 150 mM NaCl, 1% Triton X-100, 10% glycerol (pH 7.2) supplemented with complete protease inhibitor 
mixture), and homogenized by orbital shaking at 4 °C for 20 min. Homogenates were then centrifuged at 3000 x g 
for 10 min, and the supernatant was aliquoted and stored at −20°C. Protein content was determined using the 
Bio-Rad Protein Assay (Bio-Rad). 
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3.7 LIPID RAFTS ISOLATION.  
 
Lipid rafts are specific membrane domains rich in cholesterol and sphingolipids. They are resistant to 
detergent solubilisation at 4°C and are destabilized by cholesterol- and sphingolipid-depleting agents. The 
methods used to isolate the lipid rafts are based on the insolubility of these structures in the non-ionic detergent 
Triton X-100. Following ultracentrifugation on sucrose density gradients, lipid rafts will float away from the soluble 
proteins, forming a cloudy band at the top of the centrifugation tube.  
Lipid rafts or low-density Triton-insoluble complexes were isolated as previously described. Briefly, 
COS7 cells transfected with Kv7.1 and KCNE1 were washed twice in cold PBS, scrapped and centrifuged for 8 
min. The pellet was resuspended in 0.5 ml of MES-buffered saline containing 1% (v/v) Triton X-100, MES 25 mM, 
NaCl 150 mM, pH 6.5, and supplemented with protease inhibitors and homogenized by repeated passing (10 
times) through a 25G (0.4 × 1.6 mm) needle. The addition of 1.5 ml of 53.28% sucrose prepared in MES buffer 
yielded to homogenate to a final concentration of 40% sucrose and it was placed at the bottom of an 
ultracentrifuge tube. Then, a 5-30% linear sucrose gradient was formed above the homogenate and centrifuged 
at 39,000 rpm at 4ªC for 20-22 h in a SW41 rotor (Beckman Instruments, Inc, Fullerton, CA, US). A light 
scattering band confined to the 15-20% sucrose region was observed that contained endogenous caveolin used 
as a positive control, but excluded most of other cellular proteins. Gradient fractions (1 ml) were collected from 
the top, separated by SDS-PAGE and analyzed by western blotting. 
 
3.8 COIMMNUNOPRECIPITATION ASSAY 
 
For co-immunoprecipitation, 50 µl of protein G-Sepharose beads were incubated with 4 ng of KCNE1 
antibody in immunoprecipitation buffer at a final volume of 200 µl (50 mM HEPES, 150 mM NaCl, 1% Triton X-
100, 10% glycerol (pH 7.2)) and homogenized by orbital shaking at 4°C for 1 h. Antibody-bound sepharose beads 
were then washed three times with wash buffer to remove unbound antibody. 
1 mg of crude membrane protein were incubated with 25 µl of immunoprecipitation buffer-prewashed 
Sepharose protein A/G beads (Santa Cruz Biotechnology) for 1 h at 4 °C, and contaminant-bound Sepharose 
beads were separated by centrifugation for 30 s at 1000 x g at 4°C. The supernatant was incubated then with the 
antibody-bound sepharose beads by orbital shaking at 4°C for 1.5 h. During this incubation, the antibody would 
bind its specific protein (KCNE1). Sepharose beads bound to antibody-protein complexes were precipitated by 
centrifugation (30 s at 1000 x g at 4°C), and antibody-bound beads were then washed three times with 
immunoprecipitation buffer and centrifuged for 30 s at 1000 g at room temperature. Protein samples and 
immunoprecipitates were resuspended in 100 µl of Laemmli SDS loading buffer, boiled for 5 min at 100ºC, and 
then centrifuged for 3 min at 5.000 x g at room temperature. 50 µl of protein extract was separated by SDS-
PAGE and analyzed by western blotting.  
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3.9 BIOTINYLATION OF MEMBRANE PROTEINS 
 
Cell surface biotinylation was carried out with the Pierce Cell Surface Protein Isolation Kit (Pierce) 
following manufacturer's instructions. HEK293 cells were transfected with WT Kv7.1-YFP or F279I Kv7.1-YFP and 
their temporal presence at the surface was analyzed by western blotting. 24 hours after transfection, the cells 
were washed twice with chilled PBS and then, surface proteins were labeled with sulfosuccinimidyl-2-
(biotinamide) ethyl-1,3-dithiopropionate (Sulfo-NHS-SS-biotin; Pierce) and incubated at 4°C with constant rotation 
for 30 minutes. The reaction was stopped by adding quenching solution. The cells were scrapped and 
homogenated in lysis buffer (provided by the Kit). The cell lysate was sonicated at low frequencies using 5 pulses 
for 1s followed by incubation on ice for 30 min being vortexed for 5 s every 5 min. Finally the sample was 
centrifuged at 1000 x g for 2 minutes at 4°C. The supernatant was reacted with immobilized NeutrAvidin gel 
slurry in columns (Pierce) to isolate surface proteins for 1hour at room temperature. Columns were washed and 
protein was eluted in sample buffer containing DTT. Surface proteins were resolved on a SDS-PAGE gel and the 
samples were analyzed by western blotting. 
 
3.10 WESTERN BLOT ANALYSIS 
 
Cell lysates containing equal amounts of protein (20-40 µg per lane) were resuspended in Laemmli Buffer 
(10% w/v SDS, 10% v/v glycerol, 5% w/v 2-β-mercaptoethanol, 0.002% w/v bromophenol blue, 62.5 mM Tris-HCl, 
pH 7.4) and boiled at 95ºC for 5 min when determining all the antigens with. Protein extracts were loaded and size-
separated in 7-15% (acrylamide/bis-acrylamide) SDS-PAGE gels and transferred to PVDF membranes (GE 
Healthcare, UK) or to nitrocellulose membranes (Immobilon-P; Millipore). Membranes were blocked in 5% dry milk in 
PBS-Tween20 0.01% for 1 hour at room temperature and processed as recommended by the supplier of the 
antibodies against the antigens (see Table 1). Horseradish peroxidase-conjugated secondary antibodies were used 
(dilution1:10,000, Calbiochem, San Diego, CA, US). Inmunoblot signals were visualized by chemiluminescence using 
ECL-plus reagent (Amersham, GE Healthcare, UK). Quantification of band intensity was performed with the Image 
J software. 
 
Table 1. Primary antibodies used in the present Doctoral Thesis 
Antibody Type and Host Dilution Reference and Origin 
Anti-Kv1.5 Polyclonal Rabbit 1:200-1:400 APC-004, Alomone 
Anti-Kv1.3 Polyclonal Rabbit 1:200 APC-002, Alomone 
Anti-Kir2.1 Polyclonal Rabbit 1:200 APC-026, Alomone 
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Anti-Kv7.1 Polyclonal Mouse 1:200 APC-028, Alomone 
Anti-HO-1 Polyclonal Rabbit 1:1000 AB-1284, Millipore 
Anti-Arg-1 Polyclonal Rabbit 1:1000 Sc-20150, Santa Cruz Biotech 
Anti-NOS-2 Monoclonal Mouse 1:1000 Sc-7271, Santa Cruz Biotech 
Anti-COX-2 Polyclonal Goat 1:1000 Sc-1747, Santa Cruz Biotech 
Anti-Arg-2 Polyclonal Rabbit 1:500 Sc-20151, Santa Cruz Biotech 
Anti-Nrf-2 Polyclonal Rabbit 1:200 Sc-13032, Santa Cruz Biotech 
Anti-p65 Polyclonal Rabbit 1:1000 3034, Cell Signaling 
Anti- IκBα Polyclonal Rabbit 1:1000 Sc-371, Santa Cruz Biotech 
Anti- P-IκBα Monoclonal Rabbit 1:1000 2859, Cell Signaling 
Anti-phospho-IKK Polyclonal Rabbit 1:1000 2681, Cell Signaling 
Anti-IKK Polyclonal Rabbit 1:200 2678, Cell Signaling 
Anti-β-Tubulin Polyclonal Goat 1:5000 Sc-9935, Santa Cruz Biotech 
Anti-β-actin Polyclonal Goat 1:10000 Sc-1615, Santa Cruz Biotech 
Anti-GFP Monoclonal Mouse 1:1000 11814460001 Roche Applied science 
Anti-Clathrin Polyclonal Rabbit 1:1000 AB-9884, Millipore Chemicon 
Anti-Pan-Caveolin Polyclonal Mouse 1:1000 610057, BD Transduction Labs 
Anti-KCNE1 Polyclonal Rabbit 1:200 APC-008 Alomone 
 
3.11 ELECTROPHYSIOLOGICAL RECORDINGS 
 
The patch clamp technique was first used by Neher and Sakmann (1976) to resolve currents through 
single acetylcholine-activated channels in cell-attached patches of membrane of frog skeletal muscle. This 
method is a refinement of the voltage-clamp technique that uses, as an electrode, a glass micropipette pulled to a 
fine tip of approximately 1-4 µm. The recording electrode or “patch pipette” is filled with a saline solution and 
sealed (with a high resistance, G) onto a patch on the surface of the cell membrane, allowing the researcher to 
keep the voltage constant while measuring the current flowing across the membrane of a cell or even form a 
Materials and Methods 
 
36 
single channel localized in the membrane patch. 
Several configurations of the patch-clamp technique have been developed. The most commonly used 
when studying ion currents across the cell is the whole-cell patch-clamp technique. In this approach, after the 
seal is formed between the electrode and the cell membrane, a gentle suction is applied, rupturing the cell 
membrane in the patch and gaining access to the cytoplasm. Consequently, the internal pipette solution enters in 
direct contact with the intracellular space. The membrane of the whole cell is voltage clamped, and the recorded 
currents are a composite of the currents flowing through all the active channels (Figure 11).  
A variation of the same procedure is the perforated-patch technique. Here, the idea is to introduce in the 
pipette the specific pharmacologic agent amphotericin B (0.5 mg/ml) that creates large pores in the membrane 
inside the patch. The seal, therefore, is not broken. Instead, the electrode gains electric access to the intracellular 
compartment through the pores perforated by the drug and the intracellular space is not dialyzed (Figure 11). 
Before experimental use, cells were incubated with polystyrene microbeads precoated with anti-CD8 
antibody (Dynabeads M450, Dynal, Oslo, Norway). A suspension of transfected cells were placed on a chamber 
mounted on the stage of an inverted microscope. Current recordings were made with an Axopatch 200B amplifier 
(Axon Instruments, Foster City, CA, USA) in the whole cell configuration of the patch clamp technique, when 
measuring Kv1.3, Kv1.5 and Kir currents, or with the perforated patch configuration when measuring Kv7.1 
currents. As described above, experiments were performed at room temperature (20-23ºC). Current recordings 
were low pass-filtered and sampled at 2 kHz with an analog-to-digital converter DigiData 1400A (Axon 
Instruments, Foster City, CA, USA) (data acquisition system). Command voltages and data storage were 
controlled with pClamp9 software (Axon Instruments, Foster City, CA, USA). Patch electrodes were pulled from 
borosilicate glass capillaries (GD-1, Narishige, Tokio, Japan) with a P-87 puller (Sutter Instruments, Co., Novato, 
CA, EE.UU) and were heat polished (MF-83, Narishige, Tokyo, Japan). After heat-polishing, the resistance of the 
patch electrodes tip (filled with the internal solution) averaged 1-3 M. The cells were perfused continuously with 
a bath solution containing the following (in mM): NaCl 130, KCl 4, CaCl2 1.8, MgCl2 1, HEPES 10, and glucose 
Figure 11. Patch-clamp configurations. In whole cell patch clamp there is continuity between the intracellular 
space and the pipette-filling solution. Dialysis of the cytoplasm is avoided when the perforated patch is used. 
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10, and was adjusted to pH 7.4 with NaOH. The electrode solution contained the following (in mM): K-aspartate 
80, KCl 50, phosphocreatine 3, KH2PO4 10, MgATP 3, HEPES-K 10, EGTA-K 5 and was adjusted to pH 7.25 
using KOH. Gigaohm seal formation was achieved by suction (2-5 GΩ). In the experiments performed using the 
whole-cell configuration, the capacitive transients elicited by symmetrical 5 mV steps from -80 mV were recorded 
at 50 kHz and filtered at 10 kHz for subsequent calculations of capacitative surface area, access resistance and 
input impedance. Thereafter, capacitance and series resistance compensation were optimized and, usually, 80% 
compensation of the effective access resistance was obtained. Uncompensated series resistances were 4-8 M, 
as currents evoked were less than 1 nA; voltage errors from uncompensated series resistance were less than 2 
mV.  
The holding potential was set to -80 mV, and the interpulse interval was set to a minimum of 10 seconds. 
The voltage protocols were adjusted to determine the biophysical properties of wild type and mutant channels 
adequately. Time constant of activation, inactivation and deactivation were determined by fitting the current 
recordings with a single or double exponential functions: 
y = Asexp (-t/s) + Afexp (-t/f) + C 
where f and s are the system time constants, A1 and A2 are the amplitudes of each component of the 
exponential, and C is the baseline value. The voltage dependence of channel activation was fitted to a Boltzmann 
equation: 
y = 1/[1 + exp((EEh)/s)] 
in which s represents the slope factor, E represents the applied voltage, and Eh the voltage at which 50% of the 
channels are activated .  
Microcal Origin 8.5 (Microcal Software, Northampton, MA) and CLAMPFIT software were used to analyze 
data, perform least-squares fitting and for data presentation.  
 
3.12 DRUGS AND REAGENTS 
 
Table 2. Drugs and reagents used in the present Doctoral Thesis. See the results section for a more 
detailed description of each experimental condition. 
Drug/Reagent Function []final Origin 
LPS Induction of classical activation of macrophages 100 ng/µl Invitrogen 
Staurosporine Induction of apoptosis by activating caspases 1-500 ng/ml Calbiochem 
IL4 Induction of alternative activation of macrophages 20 ng/ml PrePro Tech 
IL13 Induction of alternative activation of macrophages 20 ng/ml PrePro Tech 
e-LXA4 Anti-inflammatory eicosanoid 100-500 nM Cayman 
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BocPLP Lipoxin receptor antagonist 1 µM Bachem 
Amphotericin B 
Antifungal used to create small pores in a 
membrane patch when adding to the 
internal solution 
0.5 mg/ml Sigma 
EPA Kv7.1 and KCNE1 modulators 20-100 µM Sigma 
DHA Kv7.1 and KCNE1 modulators 20-100 µM Sigma 
MG132 Potent, reversible, and cell permeable proteasome inhibitor 2 µM Calbiochem 
MCD Disruptions of lipid rafts by removing cholesterol from membranes 10 mM Sigma 
 
3.13 STATISTICAL ANALYSIS 
 
Results are expressed as mean±SEM. Direct comparisons between mean values in control conditions 
versus mean values in the presence of drug for a single variable were performed by a paired Student's t test. 
ANOVA was used to compare more than two groups. Student's t test was also used to compare two regression 
lines. Differences were considered significant if the P-value was less than 0.05.The curve-fitting procedure used a 
non-linear least-squares (Gauss-Newton) algorithm; results were displayed in linear format. Goodness of fit was 
judged by the 2 criterion and by inspection for systematic non-random trends in the difference plot.  
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4.1 MODULATION OF Kv AND Kir CURRENTS BY 15-EPI-LIPOXIN-A4 IN 
ACTIVATED MACROPHAGES. IMPLICATIONS IN INNATE IMMUNITY 
 
4.1.1 Macrophage profiling upon activation 
 
BMDM were challenged with LPS or IL4/IL13 and the expression of genes characteristics of the LPS (NOS-
2, COX-2 and IP-10) and IL4/IL13 activation (HO-1 and Arg-1) confirmed the differential phenotype of these 
populations upon treatment (Figure 12A). Interestingly, less than 20% of the cells exhibited an apoptotic phenotype 
after LPS challenge (24 h), whereas IL4/IL13 stimulation did not affect cell viability (Figure 12B), allowing the use of 
the cells for electrophysiological purposes after this primary treatment.  
Lipoxins have been described as inhibitors of the pro-inflammatory response to LPS, although the molecular 
mechanisms involved are only partially characterized (254). In this regard, treatment of BMDM with e-LXA4 
significantly impaired IKK activation and IκBα phosphorylation and subsequent degradation in response to LPS 
stimulation (Figure 12C), an effect that was further evidenced by the decreased translocation of p65 to the nucleus 
(i.e., lesser NF-κB activity) and the enhanced accumulation of Nrf-2, a transcription factor activated in response to e-
LXA4 (Figure 12D). In agreement with this pattern of signaling, a decrease in the expression of NOS-2 and COX-2 
and, interestingly, a moderate expression of HO-1 (Nrf2-dependent gene) at 10 h after e-LXA4/LPS challenge were 
observed (Figure 12E). Arg-1 and Arg-2 were not expressed under these conditions. In addition to this analysis, e-
LXA4 exhibited a moderate but significant direct inhibition of IKKβ when analyzed in vitro, using staurosporine as a 
control inhibitor (13). In agreement with previous data (254) and in part due to the attenuation of the LPS-dependent 
activation, treatment of BMDM with e-LXA4 protected against apoptosis (Figure 12F-G). 
 
4.1.2 Acute effects of e-LXA4 on Kv currents from BMDM  
 
Voltage-dependent potassium currents were evoked in BMDM by applying depolarizing pulses from a 
holding potential of -80 mV to different voltages from -80 to +60 mV in 10 mV steps. Figure 13 shows original 
records of Kv currents obtained in control (resting state), activated with LPS or with IL4/IL13 BMDM (Figure 13A-
C), before and after perfusion (15 min) with e-LXA4. Panels D-F show the current-voltage relationships (IV) 
obtained in the absence and in the presence of e-LXA4. Resting and IL4/IL13 stimulated BMDM elicited small Kv 
currents of similar magnitude that were not modified by the external perfusion with e-LXA4 (P>0.05, n=10) (Figure 
13A, C). However, LPS-stimulated BMDM elicited inactivating Kv currents of greater amplitude and perfusion with 
e-LXA4 significantly decreased them at potentials >0 mV (20±3% at +60 mV; P<0.05, n=12) (Figure 13B, E). 
Since it has been described that the increase of Kv current induced by LPS is due to an upregulation of Kv1.3 
channels (67), this early inhibition of Kv current produced by e-LXA4 could be due, at least in part, to its effects on 
Kv1.3 channels. 
Use-dependent inactivation of certain K+ channels is characterized by an inactivation that accumulates 
after repetitive depolarizations due to an incomplete recovery during the inter-pulse interval is incomplete (69,75). 
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Figure 12. Macrophage profiling after stimulation through the innate and alternative pathways and effect 
of e-LXA4 on activation. BMDM were maintained in culture and activated for the indicated period with LPS 
(100 ng/ml) or IL-4/IL-13 (20 ng/ml each). The expression of proteins characteristics of each pathway (A) were 
determined by Western blot. The extent of apoptosis/necrosis under these conditions was determined by the 
staining with annexin V and propidium iodide, respectively (B). Cells were treated with e-LXA4 (200 nM) for 30 
min prior the challenge with LPS (100 ng/ml). The activation of IKK (C) and the presence of p65 and Nrf-2 in the 
nuclei of BMDM (D) were determined at 0-120 min. Band intensities were normalized for content in β-actin (C) 
or β-tubulin (D) and the ratios P-IKK/IKK and P-IκBα/ IκBα (C) and the p65 and Nrf-2 levels (D) were 
represented as percentage over the maximal value. The effect of e-LXA4 on the protein levels of NOS-2, COX-
2, HO-1, Arg-1 and Arg-2 were determined at 10-30h (E). e-LXA4 inhibited IKKβ activity in TRF in vitro assays, 
using staurosporine as control inhibitor (F). The effect of e-LXA4 on apoptosis/necrosis in LPS activated BMDM 
was determined (G). Results show a representative experiment out of four (A, C-E) or the mean±SEM of three 
experiments. *P<0.05, **P<0.01 vs. the control condition (in the absence of stimuli). #P<0.05 vs. values 
obtained in LPS- activated BMDM cells. 
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Figure 14A-C shows the use-dependency of Kv currents in resting, LPS- and IL4/IL13-stimulated BMDM before 
and after perfusion with e-LXA4.  
The degree of use-dependent inactivation observed in resting BMDM was small 15±5% (n=10), but 
increased to 69±3% (P<0.01, n=10 vs. control) in LPS-stimulated BMDM. In contrast, stimulation with IL4/IL13 
led to a marked decrease of the use-dependent inactivation (1.6±3, P<0.01, n=8 vs. control). In none of these 
cases, the perfusion with e-LXA4 (500 nM) was able to modify the degree of use-dependent decrease of the 
current. 
As shown in Figure 14, Kv currents inactivate with a different time course in resting, LPS- and IL4/IL13-
stimulated BMDM. Inactivation parameters are useful to evaluate possible differences in the tetrameric K+ 
channel phenotype, as Kv1.3 channels present fast C-type inactivation, which is absent in Kv1.5 (17,69,259). 
Figure 14D-F shows the time course of K+ current inactivation after applying a depolarizing pulse from -80 to +60 
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Figure 13. Acute effects of e-LXA4 on Kv currents. Representative traces of Kv currents recorded in control 
(A), LPS-stimulated (100 ng/ml) (B) and IL4/IL13-stimulated (20 ng/ml) (C) BMDM for 18 h. Current recordings 
were obtained in the absence and after perfusion with e-LXA4 (500 nM). Currents were elicited by applying 
depolarizing pulses from a holding potential of -80 mV to different depolarizing voltages from -80 to +60 mV in 10 
mV steps (250 ms duration). IV relationships in the absence and in the presence of e-LXA4 (500 nM) in non-
stimulated BMDM cells (D), LPS (E) and IL4/IL13 (F) activated BMDM cells are shown. IV plots shows the 
mean±SEM. *P<0.05 vs. control; n>10 cells per group. 
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mV for 1 s. While Kv currents inactivated with a time constant of >1 s (n=5) in control BMDM, this time constant 
decreased to 456±43 ms in LPS-stimulated cells (P<0.05, n=10, vs. control). However, this process became 
much slower in IL4/IL13-stimulated BMDM (>1 s, P<0.05, n=7, vs. control). These results further support the 
notion that Kv currents generated upon depolarization in BMDM are mediated by Kv channels with different 
subunit stoichiometry after activation with LPS or with IL4/IL13. Therefore, these cytokines produce similar 
electrophysiological effects than those elicited by dexamethasone, both conditions counteracting the 
proinflammatory polarization (67,69) .
 
 
4.1.3 Acute effects of e-LXA4 on Kir channels from BMDM  
 
Inward rectifying potassium currents (Kir) were evoked in BMDM by applying pulses from a holding 
potential of -80 mV to different voltages from -140 to +40 mV in 10 mV steps (Figure 15A-C). Figure 15 shows 
original records of Kir currents and the mean IV relationships obtained in resting, LPS- and IL4/IL13-stimulated 
BMDM in the absence or presence of e-LXA4 (500 nM). In cells activated with IL4/IL13, the magnitude of the Kir 
currents was similar to that recorded in control BMDM. However, cells activated with LPS elicited Kir currents of 
smaller amplitude (-34±10 pA vs. -127±33 pA, P<0.05, n=9-11). Figure 15D-F shows the mean IV relationships 
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Figure 14. Acute effects of e-LXA4 on use-dependency and kinetics of Kv inactivation. Representative 
traces of Kv currents recorded in control (A), LPS (100 ng/ml) (B) and IL4/IL13 (20 ng/ml) (C) activated 
BMDM after applying the pulse protocol shown in the upper panel of the Figure. Plots show the normalized 
current measured at the maximum peak current during the application of a train of depolarizing pulses. 
Current records of Kv currents recorded in control (D), LPS (E) and IL4/IL13 (F) activated BMDM obtained 
after applying a depolarizing pulse of 1s at + 60 mV. Graphs show the mean±SEM of normalized current 
against the pulse number. 
 
Results 
45 
for Kir currents obtained in non stimulated, LPS- and IL4/IL13- stimulated BMDM in the absence and the presence 
of e-LXA4. The degree of Kir inactivation was greater in LPS- or IL4/IL13-stimulated BMDM cells than in non-
stimulated cells (Figure S1). Under all experimental conditions, e-LXA4 decreased the current at potentials 
negative to -120 mV (12±4%, n=10; 18±9%, n=12 and 23±4%, n=7 at -140 mV in not stimulated, LPS and 
IL4/IL13 stimulated BMDM, respectively). The decrease induced by e-LXA4 was accompanied, in not stimulated 
and LPS stimulated BMDM, by a higher degree of inactivation of the current. These early effects produced by e-
LXA4 on Kir currents may suggest ALX receptor-independent effects. 
 
4.1.4 Chronic effects of e-LXA4 on Kv and Kir channels of BMDM  
 
Since e-LXA4 produces changes in gene expression in addition to early signaling, the long-term effects of 
Figure 15. Acute effects of e-LXA4 on Kir currents. Representative traces of Kir currents recorded in control, 
LPS and IL4/IL13 activated BMDM. BMDM were not stimulated (A) treated with LPS (100 ng/ml) (B) or IL4/IL13 
(20 ng/ml) for 18h (C). Current recordings were obtained in the absence and after perfusion with e-LXA4 (500 nM) 
(A-C). Currents were elicited by applying hyper- and depolarizing pulses from a holding potential of -80 mV to 
different voltages from -140 to -40 mV in 10 mV steps (500 ms duration). IV relationships in the absence and in the 
presence of e-LXA4 (500 nM) in non-stimulated BMDM (D), or LPS (E) and IL4/IL13 (F) activated BMDM are 
shown. IV plots show the mean±SEM. *P<0.05 vs. control; n>10 cells per group. 
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e-LXA4 were analyzed on Kv and Kir currents. The effects of 18 h treatment with e-LXA4 in resting or LPS-
stimulated BMDM are shown in Figures 16-19. The effects of e-LXA4 in IL4/IL13-stimulated BMDM were not 
studied due to the slight changes produced by IL4/IL13 on Kv and Kir currents. Treatment of non-stimulated 
BMDM with e-LXA4 (18 h) did not change the Kv outward current at any membrane potential tested (Figure 16A). 
However, the combined stimulation of BMDM with e-LXA4+LPS significantly decreased Kv current at membrane 
potentials positive to -10 mV, reverting the magnitude of the current towards that observed in resting cells 
(546±152 pA vs. 178±48 pA, measured at the end of +60 mV pulses, P<0.05, n=7-9; Figure 16B). 
 
 
 
 
 
 
 
 As shown in Figure 17A-B, one of the characteristics of Kv recorded in LPS-activated BMDM is the use-
dependent inactivation observed upon application of a train of stimuli. Figure 17A-B shows the chronic effects 
induced by e-LXA4 (18 h) on the use-dependent inactivation of the Kv currents in resting and LPS-stimulated 
BMDM. e-LXA4 did not modify the degree of use-dependent inactivation in resting BMDM (Figure 17B), as shown 
in the graphs representing the normalized peak Kv current during the application of train pulses. Interestingly, Kv 
generated by BMDM activated by e-LXA4+LPS did not exhibit the use-dependent inactivation characteristic of 
Kv1.3 channels (Figure 17B). Similarly, incubation with e-LXA4 did not modify the inactivation kinetics of resting 
BMDM, whereas it slowed this process in LPS-stimulated cells (1123±335 ms vs. 456±43 ms in cells incubated 
with e-LXA4+LPS and LPS, respectively, P<0.05, n=6-11; Figure 17C-D).  
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Figure 16. Effects of long-term 
treatment with e-LXA4 on Kv 
currents. Representative traces of Kv 
currents recorded in non-stimulated 
and LPS-activated BMDM. Resting 
BMDM were incubated with e-LXA4 
(500 nM) for 18 h (A) or treated with 
LPS (100 ng/ml) and incubated with 
e-LXA4+LPS for 18 h (B). Currents 
were elicited by applying depolarizing 
pulses from a holding potential of -80 
mV to different depolarizing voltages 
from -80 to +60 mV in 10 mV steps 
(250 ms duration). IV relationships 
obtained in resting and LPS-
stimulated BMDM after incubation 
with e-LXA4 (500 nM) during 18 h (C-
D). Results show the mean±SEM. 
*P<0.05 vs. control; n>10 cells per 
group. 
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These results suggest that e-LXA4 prevents the LPS-induced changes in the stoichiometry of Kv channels, 
leading to the formation of heterotetramers with a lower Kv1.3:Kv1.5 ratio. Thus, the resulting phenotype closely 
resembles resting BMDM.  
Kir currents were recorded in BMDM by using the same pulse protocol described before and shown in the 
top of Figure 18A-B. Similarly to that observed in Kv currents, e-LXA4 did not modify Kir current magnitude vs. 
resting BMDM (Figure 18A,C). However, in LPS-activated BMDM, e-LXA4 prevented LPS effects, increasing the 
Kir current magnitude at membrane potentials negative to -90 mV (Figure18 B,D). Interestingly, in all the 
experiments in which cells were incubated with e-LXA4+LPS, e-LXA4 prevented the current biophysical 
characteristics towards the control situation. These results could be explained either by e-LXA4-induced changes 
Figure 17. Effects of long-term treatment with e-LXA4 (500 nM) on Kv inactivation. Representative 
traces of Kv currents recorded in control or incubated with e-LXA4 (500 nM) (A) and in LPS-activated or 
incubated with e-LXA4 (500 nM)+LPS (100 ng/ml) BMDM cells (B) after applying the pulse protocol shown in 
the upper panel of the Figure. Plots show the normalized current measured at the maximum peak current 
during the application of a train of depolarizing pulses. Current records obtained after applying a depolarizing 
pulse of 1 s in cells not stimulated or incubated with e-LXA4 (C) and in LPS activated or incubated with e-
LXA4 BMDM cells (D). Note that incubation with e-LXA4 prevents the LPS-induced effects on use-dependent 
and kinetics of inactivation. Results show the mean±SEM. *P<0.05 vs. LPS; n>10 cells per group. 
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in the expression of both Kv and Kir channels, or by post-translational channel protein modification. To address this 
question, the mRNA and protein levels were measured. Our data show an upregulation of the Kv1.3 mRNA by LPS 
that was impaired when cells were pre-treated with e-LXA4 (Figure 19A). e-LXA4 promoted a modest upregulation of  
Kv1.5 mRNA that was suppressed by LPS or IL4/IL13. Kir2.1 mRNA levels were downregulated by LPS, and to 
a lesser extent by IL4/IL13. Interestingly, when the protein levels were determined at 18 h (the time of evaluation of 
the biochemical and electrophysiological parameters), a significant increase of Kv1.3 and Kir2.1 protein levels were  
 
observed after challenge with LPS, an effect that was blunted by e-LXA4 (Figure 19B). The mRNA and protein level 
changes of Kv1.3 and Kv1.5 are in agreement with the electrophysiological results shown above. However, there are 
controversial results for mRNA and protein levels of Kir2.1. Moreover, the increase in the protein levels of Kir2.1 does 
not correlate with the electrophysiological results observed, which could be attributed to posttranslational 
modifications as evidenced by the appearance of two adjacent bands in LPS-activated cells. Representative confocal 
microscopy images of the distribution of the fluorescence of Kir2.1 show areas of aggregation, perhaps in specific 
intracellular environments (Figure 19C).  
In another set of experiments we wanted to assess if the changes produced by e-LXA4 in both resting BMDM 
and LPS-stimulated cells also modified either the endoplasmic reticulum release of Ca2+ or the influx via CRAC 
channels. Treatment of BMDM with thapsigargin (TG) induced in a transient increase in the [Ca2+]i due to calcium 
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Figure 18. Effects of long-term 
treatment with e-LXA4 (500 nM) on Kir 
currents. Representative traces of Kir 
currents recorded in resting and LPS-
activated (100 ng/ml) BMDM (A-B, top 
panels). Resting and LPS-stimulated 
BMDM incubated with e-LXA4 for 18 h 
(A-B, bottom panels). Currents were 
elicited by applying hyper- and 
depolarizing pulses from a holding 
potential of -80 mV to different 
depolarizing voltages from -140 to -40 
mV in 10 mV steps (500 ms duration). IV 
relationships obtained in resting and 
LPS-stimulated BMDM cells after 
incubation with e-LXA4 during 18 h (C-
D). IV plots show the mean±SEM. 
*P<0.0 vs. control; n>10). 
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efflux from the intracellular stores. Subsequent addition of Ca2+ (1 mM) to the extracellular medium produced a further 
increase in [Ca2+]i indicative of store-operated calcium entry. Figure 20 shows the effects produced by e-LXA4 in 
Figure 19. Effects of e-LXA4 on Kv1.3, Kv1.5 and Kir2.1 expression in activated BMDM. Cells were 
incubated with 200 nM e-LXA4 for 30 min prior to activation with LPS (100 ng/ml) or IL4/IL13 (20 ng/ml 
each). The mRNA levels of the channels were determined at 6 h after activation by real-time PCR (A), and 
the protein levels of the channels were determined at 18 h by Western blot using specific Abs (B). 
Immunolocalization of Kir2.1 was determined by confocal microscopy after 20 h of stimulation with the 
indicated ligands and the intensity of the fluorescence was quantified using Image J software (C). Data show 
the mean±SEM of three experiments (A, C), representative blot out of three with indication of the relative 
band intensity (B) and representative immunocytochemistry images (C). *P<0.05, **P<0.01 vs. the control 
condition; #P<0.01 vs. the same condition in the absence of e-LXA4. Veh: vehicle. 
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resting and LPS-stimulated BMDM on calcium release and calcium influx. Under all experimental conditions, Ca2+ 
release from intracellular stores was similar. When analyzing the Ca2+ influx mainly via CRAC channels, we observed 
that under resting conditions, e-LXA4 did not produce significant changes in the fluorescence. The increase in 
fluorescence was greater in LPS-stimulated BMDM (P<0.01) and, interestingly, e-LXA4 significant decreased 
fluorescence values in LPS-stimulated BMDM (P<0.01) (Figure 20). 
 
 
 
4.1.5 e-LXA4 produces its effects partially via ALX receptor 
 
The biological effects of e-LXA4 have been described to be mediated, at least in part, via ALX receptor 
(260,261). Using a selective ALX inhibitor (BocPLP; 1 µM) (262,263) >85% inhibition of the e-LXA4 dependent 
Figure 20. Effects induced by e-LXA4
treatment on calcium handling. BMDM were
resting or treated with e-LXA4 (200 nM), LPS
(100 ng/ml) or e-LXA4 (200 nM) + LPS (100
ng/ml) during 18h. Then cells were loaded with
FLUO4 and the calcium release (induced by
thapsigargin) or calcium influx (induced by the
addition of 1 mM CaCl2) was detected using
confocal microscopy. Results show the
increment of fluorescence mean±SEM,
*P<0.01vs. resting BMDM and #P<0.01 e-
LXA4+LPS vs. LPS BMDM n>8 cells per group. 
Figure 21. e-LXA4 produces its effects partially via interaction with ALX. Effects of pre-treatment with e-LXA4 on Kv
currents recorded in LPS-activated BMDM in the presence of an ALX antagonist (BocPLP). Kv currents were slightly
reverted vs. those recorded in LPS-activated BMDM pre-treated with e-LXA4 (A). Similar effects were observed on the
use-dependent inactivation (B) and on the time course of inactivation observed after applying 1s-depolarizing pulses (C).
Kir currents were reverted versus Kir currents recorded in LPS-activated BMDM pretreated with e-LXA4 (D). Note that the
effects of e-LXA4 on Kv were slightly receptor-dependent, whereas those produced on Kir current are highly receptor-
dependent. n>10 cells per group. IV plots show the mean±SEM. *P<0.05 vs. control; n>10. 
 
BocPLP+e-LXA4+
LPS 18 h
BocPLP+e-LXA4+
LPS 18 h
BocPLP+e-LXA4+
LPS 18 h
Pulse
B
-80 -60 -40 -20 0 20 40 60
0
100
200
300
400
500  CTRL
 LPS 
 e-LXA4+LPS18 h
 BocPLP+e-LXA4+
         LPS 18 h
-40 mV
50 ms
10
0 
pA
2 4 6 8 10 12 14
0.4
0.6
0.8
1.0
1.2
50 ms
50
 p
A
A
-40 mV
-80 mV
+60 mV +60 mV
-80 mV
250 ms
C
ur
re
nt
 (p
A)
N
or
m
al
iz
ed
 c
ur
re
nt
2 Hz
(n=15)
Vm (mV)
-140 -120 -100 -80 -60 -40
-160
-120
-80
-40
0
 CTRL
 LPS 
 e-LXA4+LPS 18 h
 BocPLP+e-LXA4+
         LPS 18 h
Vm (mV)
DC
LPS
BocPLP+e-LXA4+LPS  
e-LXA4 +LPS CTRL
200 ms
10
0 
pA
-80 mV
+60 mV
-40 mV
C
ur
re
nt
 (p
A)
-140 mV
20
 p
A
100 ms
-40 mV -80 mV
1s 500 ms
Results 
51 
ERK phosphorylation was observed (data not shown). Figure 21 shows the effects of BocPLP on Kv and Kir 
currents and the IV relationships in different combinations of LPS and e-LXA4 BMDM treatments, indicating that 
the effects of e-LXA4, on both Kv and Kir, appear to be partially mediated via ALX receptor. The biophysical 
characteristics of Kv currents were very similar to those recorded in cells activated with LPS and to a lesser extent 
to e-LXA4+LPS. However, as shown in the Kv IV relationship (Figure 21A), the mean magnitude of the current 
resulted to be slightly smaller than that recorded in cells activated with LPS, and somewhat greater than that 
obtained after stimulating with e-LXA4+LPS (Figure 21A).  
In addition, Kv currents still exhibit cumulative inactivation as occurred in LPS stimulated cells in the 
absence of e-LXA4 (Figure 21B). Regarding this effect, the Kv inactivation recorded in BMDM stimulated with e-
LXA4+LPS in the presence of BocPLP was intermediate between those observed in LPS and e-LXA4+LPS 
stimulated cells (Figure 21B,C), suggesting that the effects of e-LXA4 on Kv currents are partially ALX-receptor 
dependent. In agreement with this hypothesis is the fact that a significant reduction of Kv current was observed 
when LPS-stimulated BMDM were perfused with e-LXA4. Concerning the effects of BocPLP on the Kir current in 
BMDM stimulated with e-LXA4+LPS, we observed that the inward current was similar to that recorded in LPS-
activated BMDM (Figure 21D). 
 
4.1.6 e-LXA4 effects are dose-dependent 
 
Finally, since antiinflammatory actions of e-LXA4 have been also observed at very low concentrations, 
the effects of 100 nM e-LXA4 were analyzed on Kv and Kir currents recorded in BMDM activated with LPS (Figure 
22). As shown in Figure 22, the effects of 100 nM e-LXA4 on the magnitude of Kv currents were smaller than 
those induced by 500 nM e-LXA4. Moreover, pre-treatment with 100 nM e-LXA4 did not abolish the use-
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dependent inactivation, as 500 nM did (Figure 22B). In addition, the time course of inactivation was very similar to 
that observed in BMDM activated with LPS (Figure 22C). Concerning to the action of 100 nM e-LXA4 on Kir 
channels, this lower concentration partially reverted the effects induced by LPS, but to a lesser extent than 500 
nM e-LXA4 (Figure 22 A,D). All these results suggest that the effects of e-LXA4 are concentration-dependent. 
. 
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4.2 EFFECTS OF n-3 PUFAs ON Kv7.1/KCNE1 CURRENT 
 
4.2.1 EPA and DHA increase Kv7.1/KCNE1 current magnitude 
 
 The concentration of EPA or DHA (20 µM) used in this study was selected on the basis of the free fatty 
acid levels in the plasma of 6 patients included in the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia 
(SOFA) trial (264) who were taking 2 g/day fish oil. In this clinical trial, plasma free fatty acids were measured by 
gas-liquid chromatography (265). From this study it was showed that the average concentration of free EPA and 
DHA was 10 µM (range, 5.0 to 16.4 µM). Figure 23A shows original Kv7.1/KCNE1 records obtained after 
applying 12 s depolarizing pulses from a holding potential of -80 mV to +60 mV in the absence and in the 
presence of 20 µM EPA and DHA. Both PUFAs increased the current magnitude by 37.3±6.2% (P<0.05, n=13) 
and 82.8±27.0% (P<0.05 n=13) for EPA and DHA respectively. The increase induced by EPA was time-
dependent, being this effect greater when the current magnitude was measured after longer depolarizing pulses 
(3.6±6.2%, 28.4±5.3%* and 37.3±6.2%* after 1.5, 5.5 and 12 s, respectively, *P<0.05, n=5-13).  
 The onset of Kv7.1/KCNE1 activation, after 150 ms, is better described by a two exponential process. 
Figure 23B shows the normalized currents obtained under control conditions and after exposure to EPA (20 µM) 
and DHA (20 µM). This process followed a biexponential process. Under control conditions, the activation time 
constants arose mean values of f=737±53 ms and s=4604±542 ms (n=16). The most relevant effect produced 
by EPA was to slow the activation kinetics due to an increased contribution of the slow component to the to the 
Figure 23. Acute effects of DHA and EPA on Kv7.1/KCNE1 current. Effects of EPA and DHA (20 µM) on the 
current elicited by the activation of Kv7.1/KCNE1 during depolarizing pulses from a holding potential of -80 mV to +60 
during 12 s. (A): Original traces of Kv7.1/KCNE1 obtained in the absence and in the presence of EPA (top) or DHA 
(bottom). (B): Normalized traces to matching control. The inset represents the plot of the As/(As+Af) in control and in 
the presence of each PUFA. (C): Tail currents recorded at -40 mV after the application of 5.5s depolarizing pulse to 
+60 mV in the absence and in the presence of each PUFA. Results show the mean±SEM. *P<0.05 vs. control; n=8-
16 cells per group. 
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total activation process (As/(As+Af)=0.23±0.04 vs. As/(As+Af)=0.64±0.05 for control and acute EPA respectively, 
P<0.05, n=8) (Figure 23B inset). The time constants were not modified (f =653±56 ms and s=4106±796 ms, 
P>0.05, n=8). In the presence of DHA, the total activation process was also slowed due to an increased 
contribution of the slow component of activation (As/(As+Af)=0.19±0.04 vs. As/(As+Af)=0.46± 0.07, for control and 
acute DHA respectively P<0.05, n=8). However, DHA slightly accelerated the fast component of activation 
(f=592±52* ms and s=3506±560 ms, *P<0.05, n=8). The increase of the current induced by DHA was not time 
when measured after 1.5, 5.5 or 12 s depolarizing pulses (91.8±19.3%, 92.7±23.8% and 82.8±26.9%, P>0.05, 
n=4-13, respectively). 
Tail currents were elicited upon repolarization to -40 mV after each voltage step. An increase in the tail 
current magnitude of 12.6±5.2% (P<0.05, n=13) and 27.3±13.3% (P<0.05, n=9) after exposure to EPA and DHA, 
respectively was observed, being this increase similar for both PUFAs (Figure 23C). Under control conditions the 
deactivation exhibited monoexponential kinetics. EPA and DHA modified the deactivation kinetics, in such a way 
that in the presence of either PUFA the kinetics of the tail currents became biexponential (Table 3). 
 
Table 3. Time-dependent effects of EPA and DHA (20 µM) on the deactivation process of 
Kv7.1/KCNE1 channels. Tail currents were recorded at -40mV pulses after a depolarizing pulse to 
+60mV of 5.5s in duration and were fitted to a monoexponential function or a biexponential funtion in the 
case of EPA. 
 
 
4.2.2 Voltage-dependent effects of acute EPA 
 
Figure 24 shows the voltage-dependent effects produced by EPA on Kv7.1/KCNE1 current. Figure 24A 
shows current records obtained in the absence and in the presence of EPA when applying 5.5 s depolarizing 
pulses from -80 mV to +60 mV in 10 mV-steps from a holding potential of -80 mV. After the application of 
depolarization pulses, membrane potential was repolarized to -40 mV to record the tail currents. EPA (20 µM) 
increased the amplitude of the current at all membrane potentials tested positive to -10 mV (Figure 24B). EPA 
shifted the midpoint of the activation curve towards more negative potentials (+22.3±6.6 mV vs. +13.5±5.5 mV, 
before and after perfusion with EPA, P<0.05, n=5) without modifying the slope values (16.7±1.3 mV vs. 18.6±1.7 
mV, P>0.05, n=5) (Figure 24C). In Figure 24D the relative current in the presence of EPA was plotted versus the 
membrane potential. The maximal increase occurred at 10 mV. This effect might be due to the negative shift of 
the activation curve, suggesting that the primary mechanism of the increased magnitude of Kv7.1/KCNE1 might 
be due to an effect on channel gating. Similar qualitative effects were produced by DHA, although this PUFA did 
not significantly shift the midpoint of activation or the slope factor of the activation curve (Figure S2). 
CONTROL Acute EPA 20 µM CONTROL Acute DHA 20 µM 
 (ms) f (ms) s (ms)  (ms) f (ms) s (ms) 
531.4±52.9 121.3±7.0 490.0±110.9 585.0±63.2 131.8±18.2 695.6±118.8 
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4.2.3 Acute versus chronic effects of EPA on Kv7.1/KCNE1 current 
 
It has been described that increased consumption of n-3 PUFAs leads to increased blood levels of n-3 
PUFAs (264,266) and n-3 PUFAs incorporation to various tissues (267). However, the relative contribution of 
acute versus long term administration on the electrophysiological effects on ion currents has not been 
determined. In order to differentiate the acute from the possible chronic effects of EPA and DHA, three different 
approaches were used. Firstly, the electrophysiological properties of Kv7.1/KCNE1 after incubation of COS7 cells 
for 48 h with EPA 20 µM in serum-free medium were assessed. Chronic incubation with EPA did not alter the 
activation kinetics of Kv7.1/KCNE1 (f=737±53 ms and s=4604±542 ms vs. f=613±62 ms and s=5376±1745 
ms, P>0.05, n=5-16, for control conditions and chronic EPA respectively, Figure 24A, 25A). However, the 
activation process was slightly accelerated compared to acute EPA due to a reduced contribution of the slow 
component to this process (As/(As+Af)=0.56±0.04 vs. As/(As+Af)=0.30±0.06, for acute and chronic EPA 
respectively, P<0.05, n=5-8). The tail current kinetics was faster than under control conditions, becoming a 
biexponential process (f=179±16 ms and s=628±95 ms). However, the fast time constant of deactivation, was 
slower than when EPA was added acutely (f=179±16 ms vs. f=124±7 ms, for chronic and acute EPA 
respectively, P<0.05, n=5-18) (Figure 25C)  
It is interesting to note that chronic EPA induced a more depolarized threshold of activation in 
Figure 24. Voltage dependent effects of acute EPA on Kv7.1/KCNE1 current. (A): Traces obtained after applying 
the pulse protocol shown in the top in the absence and in the presence of EPA. (B): IV relationship obtained under 
control conditions and after perfusion with EPA. (C): Activation curves obtained under control conditions and after 
perfusion with EPA. (D): Graph showing the ratio between the current obtained in the presence of EPA and that 
under control conditions. Results show the mean±SEM. *P<0.05 vs. control; n=5 cells. 
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comparison with control values (-10 mV vs. 0 mV for control conditions and chronic EPA respectively) (Figure 
25C).This effect was accompanied by a shift of the activation curve towards more positive potentials 
(Vmid=24.8±2.6 mV vs. Vmid=34.4±3.9 mV, P<0.05, n=14-5, for control conditions and chronic EPA respectively) 
(i.e. EPA induces opposite effects after incubating the cells with this PUFA during 48 h than when they were 
perfused acutely with this PUFA (Figure 25D).  
 
4.2.4 Effects of EPA incubation on Kv7.1 and KCNE1 protein levels 
 
In a previous study (212), it was reported that chronic treatment (48 h) with EPA and DHA, but not with 
α-linolenic acid, decreased protein levels of Kv1.5 in Ltk- cells. Thus, our second approach was to analyze if 
chronically applied EPA and DHA were able to modify the expression pattern of Kv7.1 and KCNE1 proteins. In 
order to asses this issue, COS7 cells were transfected with Kv7.1-YFP alone or together with KCNE1-CFP, and 
the levels of Kv7.1 and KCNE1 were measured by western blot. Under both experimental conditions, EPA (30 and 
100 µM) reduced the levels of Kv7.1 protein in a concentration-dependent manner (Figure 26A) but not those of 
KCNE1 (Figure 26B). Since COS7 cells were transiently transfected with the cDNA encoding Kv7.1 was cloned 
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Figure 25. Electrophysiological effects of chronic incubation (48 h) with EPA on Kv7.1/KCNE1. (A): Currents 
are shown for depolarizations from -80 mV to voltages between -80 and +60 mV in steps of 10 mV. Tail currents 
were obtained on return to -40 mV. (B): IV relationship obtained after measure the current after 5.5 s at all 
membrane potentials. (C): Original tail records obtained during repolarization to -40 mV after a 5.5 s depolarization 
to +60 mV. (D): Activation curves of Kv7.1/KCNE1 current obtained after representing the normalized tail current 
amplitude versus the previous step potential recorded in cells incubated for 48 h with EPA. Results show the 
mean±SEM of 4-8 cells per group. 
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into a vector with a CMV promoter, it is unlikely that EPA would decrease the expression of Kv7.1. In addition, it 
has been demonstrated that internalization and stability of Kv7.1 is regulated by ubiquitylation (268) and that n-3 
PUFAs are able to modify the activity of the proteasome. Therefore, the decrease in Kv7.1 protein level might be 
due to a higher degree of Kv7.1 degradation via proteosoma. Hence, a series of experiments in the presence of a 
proteasome inhibitor (MG132, 2 µM) were performed. Figure 26C shows western blots of these experiments as 
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Figure 26. EPA decreases steady-state levels of Kv7.1 protein. (A): Left: Shown are representative 
western blots that illustrate treatments with EPA. Note that EPA induces dose-dependent reductions of Kv7.1 
protein. Cellular lysates were prepared from COS7 cells transiently expressing Kv7.1 and incubated for 48 h 
with EPA at two concentrations (30 and 100 μM). Right: Bar graph summarizing densitometry measurements 
used to compare protein levels for the treatments of EPA for 48 h. β-actin levels were used as a loading 
control (*P<0.05, n=3-4). (B): Representative western blots and graph showing the effects of EPA (30 and 
100 µM) on KCNE1 in cells transfected with Kv7.1/KCNE1. (C): Representative western blots and graphs 
showing the effects of EPA (30 and 100 µM) on Kv7.1 in the presence of MG132 (proteasome inhibitor). Bar 
graphs shows the mean±SEM of 3-4 experiments per group. *P<0.05 vs. control 
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well as the quantification of the images referred to the β-actin used as a load control. Under these experimental 
conditions, EPA did not produce any change in the protein levels of Kv7.1, thus suggesting that EPA induces 
degradation of Kv7.1 via proteasome. Similar results were obtained when the cells were treated with DHA (Figure 
S3). 
 
4.2.5 Effects of EPA on the location of Kv7.1 and KCNE1 subunits in the plasma membrane 
 
Kv7.1 channels and KCNE1 subunits target lipid rafts in eukaryotic cells (269). Lipid rafts are membrane 
microdomains enriched in cholesterol and sphingolipids. Because of their high lipid content, lipid rafts are 
detergent insoluble at 4ºC, allowing the identification and study of lipid rafts-associated molecules in density 
gradients after centrifugation. As mentioned before, dietary administration of n-3 PUFAs leads to the 
incorporation of these compounds into all membranes including myocardial membranes of the heart (195,213). 
Once incorporated, n-3 PUFAs alter the lipid composition and protein distribution of the membrane lipid raft and 
thus the environment of the ion channel, which could affect its function. Thus, the third approach we used was to 
analyze possible changes in the location of Kv7.1 and/or KCNE1 in lipid rafts. 48 h post-transfection, lipid rafts 
were purified from low density fractions (top fractions) of flotation gradients. Figure 27 shows the distribution of 
Kv7.1 and KCNE1 over the sucrose gradient under control conditions and after incubation with EPA for 48 h. As 
previously described, both channel subunits target lipid rafts. EPA triggered a wider distribution of Kv7.1 and 
KCNE1 that can account, at least in part, for some of the electrophysiological changes observed on 
Kv7.1/KCNE1. Similar results were obtained when the cells were treated with DHA (Figure S4). 
 
4.2.6 Effects of cholesterol depletion on Kv7.1/KCNE1 current 
 
Association with lipid rafts is an important mechanism for signaling protein and ion channel function. 
Changes in the composition of these microdomains or their complete disruption modify the activity of several ion 
channels. For example, it was found that lipid raft disruption increased the transient receptor potential cation 
channel subfamily M member 8 (TRPM8) current suggesting that channel activity is higher outside of these 
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Figure 27. Chronic effects of EPA on Kv7.1 and KCNE1 location. Sucrose density gradient fractions of cells 
expressing Kv7.1 and KCNE1 in the absence (A) or in the presence of EPA (B). Caveolin indicated floating lipid rafts 
with low density, clathrin labeled non-raft fractions. Kv7.1 and KCNE1 colocalized with caveolin in low-buoyant 
density fractions (fractions 2-6) in control experiments, whereas EPA triggered a wider distribution of proteins 
(fractions 1-12) and rafts. Pictures are representative images of at least 3 independent lipid rafts extractions 
analysed by western blot. 
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microdomains (270).  
As we found that n-3 PUFAs modifiy the association between these potassium channels and lipid rafts, 
we wanted to analyze the electrophysiological consequences of the disruption of these structures on 
Kv7.1/KCNE1. To that end, COS7 cells were perfused with different external solutions in the following order: 1) 
methyl-beta-cyclodextrin (MβCD, 10 mM), agent capable to deplete membrane cholesterol; 2) EPA 20 µM and 3) 
drug-free external solution. Upon perfusion of the cells with MβCD, an increase of the Kv7.1/KCNE1 was 
observed at membrane potentials positive to +30mV and a decrease of the current at membrane potentials 
negative to +30 mV (Figure 28A-E). These effects appeared in a parallel way to a positive shift of the activation 
curve +23 mV (P<0.05, n=4) (Table 4). Under these experimental conditions, perfusion with EPA produced 
similar effects than those observed in cells non-treated with MβCD. Indeed, EPA produced an increase of the 
current at membrane potentials negative to +40 mV and did not shift the midpoint of the activation curve in 
comparison to that obtained in the presence of MβCD, but it increased its slope factor (Table 4). The effects 
produced by EPA were accompanied by the typical slowing down of the activation kinetics that was due to the 
abolishment of the fast component of the activation process (Table S1A) and the appereance of a second 
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Figure 28. Effects of acute EPA in membrane cholesterol depleted cells. (A): Representative traces of 
Kv7.1/KCNE1 current under control conditions, after perfusion with MβCD for 40 min, perfusion with EPA and 
washout with EPA-free external solution. All records were obtained from the same cell. (B): IV relationships under 
these experimental conditions. (C): Graph showing the ratio between the current magnitudes obtained after perfusion 
with MβCD divided by current under control conditions, as well as current recorded in the presence of EPA divided 
by current recorded after perfusion with MβCD. Activation curves obtained under all the experimental conditions 
before (D) and after normalization (E). IV and activation curve plots showing the mean±SEM of 4 cells. 
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component of deactivation, becoming this process biexponential (Table S1B). EPA effects produced in cells 
cholesterol depleted with MβCD were reversible, not only in the magnitude of the current, but also in the kinetics 
and in the activation curve (Figure 28).  
 
Table 4. Modulation of the gating properties of Kv7.1/KCNE1 channels by acute EPA in cholesterol 
depleted cells. Results show the mean±SEM of 4 cells. *P<0.05 vs. the control condition and #P<0.05 
vs. MβCD 10 mM perffusion. Currents were elicited in 10-mV increments to test potentials ranging from -
80 to +60 mV from a holding potential of −80 mV. Peak tail currents were measured, and the normalized 
data were fit to a Boltzmann function. 
CONTROL MβCD 10 mM EPA 20 µM MβCD 10 mM 
Vmid (mV) s (mV) Vmid (mV) s (mV) Vmid (mV) s (mV) Vmid (mV) s (mV) 
18.9±3.6 15.7±4.1 42.2±5.9* 15.2±4.1 48.3±2.8 26.8±5.1*# 43.9±6.8 15.6±1.2 
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4.3 A NEW MUTATION ON Kv7.1 ASSOCIATED WITH SHORT QT SYNDROME 
 
4.3.1 Patient characteristics: clinical analysis and genetics 
 
The index case of the family was a 37 years old man who dropped dead unexpectedly while working as 
a postman. Apparently, he had no history of syncopal episodes nor other cardiac symptoms prior to death, and 
the information obtained from relative’s interview did not demonstrate the cause of the death. Full report from 
post-mortem study was not available to review.  
 His son, an athletic and healthy 23 years old was referred recently for cardiac evaluation. ECG showed 
sinus bradycardia of 55 bpm, normal PR, QRS, and a slightly short QTc interval of 356 ms with prominent T 
waves in V2-V4 (Figure 29A). Exercise test was normal of note; QTc was shortened with the exercise, measuring 
350 ms at maximum workload. Echocardiogram and cardiac magnetic resonance demonstrated a normal heart, 
and 24-hours Holter monitoring showed no arrhythmias. Cardiac evaluation of the asymptomatic 13 years old 
daughter demonstrated normal ECG, Holter, exercise test, echocardiogram and cardiac magnetic resonance. In 
particular corrected, QTc was 400 ms. In the absence of DNA available from the deceased father, a blood sample 
from the patient and from his sister was sent for genetic study of most prevalent genes related to 
Figure 29. Electrocardiogram of the patient and genetic analysis. (A) Twelve-lead ECG of an affected 
individual (III-9). (B). Screening of the genes more prominent for cardiac arrhythmias. (C) DNA and amino acid 
sequence of Kv7.1 missense mutation found in the patient and also in a blood sample of his sister and sequence
alignment of the other members of the Kv7 family, Kv1.2 and shaker channels. 
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channelopathies. Genetic studies on the patient’s DNA excluded mutation in KCNH2, SCN5A, KCNE1, KCNE2, 
KCNJ2 and RyR2. Analysis of the KCNQ1 gene revealed a novel heterozygous mutation, a single-base 
substitution at nucleotide 127910 (g.127910T>A) in the exon 6 of the KCNQ1 gene, resulting in an amino acid 
change from phenylalanine to isoleucine at 279 in Kv7.1 (p.F279I)) within the S5 transmembrane domain, which 
was not reported before (Figure 29B-C). 
 
4.3.2 Characterization of F279I mutation on Kv7.1 channel function 
 
The electrophysiological consequences of the F279I Kv7.1 mutation, located in the S5 region of the 
Kv7.1 channel, were characterized after heterologous expression in COS7 cells. Currents were elicited by 5.5 s 
pulses to potentials ranging from -80 mV to +100 mV from a holding potential of -80 mV in 20 mV steps. In 
response to membrane depolarization, both WT and F279I Kv7.1 generated outward rectifying potassium current 
that fully activate during the 5.5 s pulse with an exponential activation time course and a threshold for activation 
of approximately -20 mV for WT and -40 mV for F279I Kv7.1 channel (Figure 30A-B). Upon repolarization to -50 
mV, WT Kv7.1 tail currents were characterized by an initial increase as channels recovered from inactivation, 
followed by a slow decay as channels deactivated (139,140). However, mutant tail currents did not display this 
Figure 30. Current induced by expression of WT and mutant F279I Kv7.1 channels in COS7 cells. 
Representative currents for COS7 cells transfected with (A): WT or (B): F279I Kv7.1 mutant channels. The 
voltage protocol is shown on the top. (C): IV relationships of measured at the end of a 5.5 depolarizing pulse for 
WT and F279I Kv7.1 channels. (D): Voltage dependence of activation: activation curves were obtained by plotting 
the normalized tail currents versus the membrane potential. The fit with a Boltzmann equation is shown with a 
solid line. Results show the mean±SEM of 8-9 cells per group. 
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typical hooked configuration. The lack of a hook in the tail current suggested either these channels did not 
inactivate at positive potentials or that recovery from inactivation was very fast. The average IV relationships 
determined with 5.5 s pulses for WT and F279I Kv7.1 are plotted in Figure 30C. The current magnitude was 
increased by about 50% compared with WT Kv7.1 at potentials between +0 mV and +40 mV (P<0.05, n=8-9), but 
at positive potentials this increase was not statistically significant. Thus, a decrease in the side chain or the lack 
of an aromatic residue in the S5 transmembrane domain at F279 position altered the gating of Kv7.1. To 
determine the voltage dependence of activation, the peak amplitudes of tail currents recorded at -50 mV were 
plotted as a function of the test pulse potential, normalized and fitted to a Boltzmann equation (Figure 30D). The 
midpoint potential of the activation curve Vmid was -21.2±1.9 mV and the slope factor 9.9±1.9 mV for WT Kv7.1 
channels. In the case of F279I Kv7.1channels the Vmid was -22.9±1.9 mV (P<0.05, n=9) and the slope factor 
8.1±0.5 mV (P>0.05, n=9).  
 
4.3.3 Inactivation is reduced by the F279I mutation 
 
Inactivation of WT Kv7.1 channels is indirectly revealed by the hooked tail currents, which reflect 
recovery from the inactivation process (139,140,271). To investigate whether the apparent increase in the steady-
state currents of the F279I Kv7.1 channel could be explained by an altered inactivation properties, we applied a 
triple pulse protocol to direct measure the channel inactivation (272-274) (Figure 31). The first depolarizing pulse 
opened and inactivated the channels. By applying a second pulse (4 ms and 20 ms) to -130 mV, a number of the 
inactivated channels will reenter the open state. Deactivation is minimized by the short pulse duration. If channels 
recovered from inactivation during the second pulse, then current inactivation was observable during a 
subsequent depolarization applied to the same potential as the first pulse (+40, +60, +80 or +100 mV). In Figure 
31A-B, representative traces obtained with this triple pulse protocol are shown. We estimated the fraction of 
channels that inactivated during the third pulse. The degree of channel inactivation for WT channels was larger 
after a 20 than a 4 ms pulse, indicating that the 4 ms pulse to -130 mV was insufficient to allow adequate 
recovery of WT channels from inactivation and exhibited a linear relation with the increasing voltage, suggesting 
that this process is voltage independent. Compared to WT, F279I mutant channels exhibited a diminished fraction 
of channel inactivation at every voltage tested. F279I Kv7.1 channels were partially inactivated during pulses to 
+80 and +100 mV but not during pulses to +40 and +60 mV. These data indicate that F279I Kv7.1 channels can 
only inactivate at potentials far more positive than those observed for WT Kv7.1 channels. These data are 
consistent with the non hooked tails observed after repolarization at -50 mV (Figure 30).  
It has been reported that mutations of residues within the pore region spanning S5 to S6 affect Kv7.1 
inactivation (118,125), indicating a possible involvement of this region on this process. Furthermore, experiments 
performed with functional quimeras between the closely related channels Kv7.1 and Kv7.2 (a component of the 
neuronal non-inactivating M-current) indicated that the borders of the crucial region for inactivation could be 
assigned to the S5 transmembrane segment and parts of the P-loop (144). Similarly, the mutation V307L 
(responsible of short QT) located in the pore loop showed slightly slowed activation and deactivation kinetics 
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compared with WT, but again abolished inactivation (144). Therefore, a reduced level of inactivation could 
account for the bigger steady-state current amplitudes observed for the F279I Kv7.1 mutant channel.  
 
4.3.4 Properties of the WT and F279I Kv7.1/KCNE1 channel complexes 
 
As reported previously (135,136), coexpression of WT Kv7.1 and KCNE1 subunits induce a large, slowly 
activating current similar to cardiac IKs. To investigate the effect of the F279I mutant in this more physiologically 
relevant channel configuration, either 0.5 µg WT Kv7.1 or the mutant F279I subunit were co-transfected with 0.5 
µg KCNE1. The mutant channel complex F279I/KCNE1 displayed ~1.8 fold acceleration of the fast component of 
the activation kinetics in comparison to the WT Kv7.1/KCNE1 complex (794.1±36.0 ms vs. 445.7±27.9 ms, 
P<0.05, n=8-9) and was thus kinetically situated intermediate between WT Kv7.1 and WT Kv7.1/KCNE1 channel 
complexes. Furthermore, the initial sigmoidal activation, characteristic of WT Kv7.1 associated with KCNE1, was 
no longer obvious (Figure 32A-B). This acceleration might be indicative of an impaired alpha-beta interaction. In 
fact, it has been described that substitutions at this residue by the smaller amino acid alanine, strongly disturbed 
the KCNE1 gating modulation. In contrast, the deactivation kinetics of the mutant channel complex F279I/KCNE1 
was similar to that of WT Kv7.1/KCNE1 complex. The deactivation process of F279I mutant channels was slighly 
faster compared with WT channel complexes but was not significantly different (Figure S5).  
The average current induced by co-expression of F279I Kv7.1 and KCNE1 at the end of a 5.5 s 
depolarizing pulse was higher at potentials between -20 to +20 mV (which is physiologically relevant), but this 
Figure 31. F279I mutation reduces Kv7.1 inactivation assessed with a three pulse protocol. The three
pulse protocol is shown on the top. Currents were recorded from cells transfected with WT or F279I Kv7.1
cDNA. Cells were pulsed to a test potential of +40, +60, +80, or +100 mV for 2 s before applying a 20 ms (A) or
4-ms (B) interpulse to -130 mV to allow channels to recover from inactivation. The membrane potential was
returned to the test potential after the interpulse to measure the extent of inactivation.*P<0.05, n=9-12 
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effect was reverted at potentials positive to +40 mV (Figure 32C). Furthermore, the mutant channel starts to 
display accumulate of the current amplitude at potentials at around +80 mV. This effect could be due to the 
presence of an inactivated state that according to the model of Silva and Rudy (146,275), is absent in WT Kv7.1 
WT/KCNE1, suggesting again an impaired functional interaction with KCNE1 (Fig 32A-B). Mean current was also 
measured 300 ms after the step change in membrane potential to more accurately reflect the duration of a 
cardiac action potential (Figure 32D). The mutant current magnitude was higher at every potential tested positive 
to 0 mV, which could be explained by the faster activation kinetics of the mutant channel. As illustrated in Figure 
32E, the voltage dependence of channel opening for the mutant channel was shifted towards more negative 
potentials, as well as the threshold for channel opening, but the slope of the voltage sensitivity was unchanged 
(Figure 32C-E). Altogether, the shift in the activation curve and the faster activation kinetics indicate that mutant 
F279I Kv7.1/KCNE1 channels open faster and that more channels will be open at physiological relevant plateau 
potentials. These biophysical properties would therefore predict an increase of the repolarizing potassium current 
and thus, a gain of function.  
 
4.3.5 Subcellular location of WT and F279I Kv7.1/KCNE1 channel complexes 
 
The electrophysiological analysis of the F279I Kv7.1/KCNE1 channel complex revealed an altered 
interaction with the accessory subunit. Therefore, in order to test if this effect could be due to a reduced physical 
Figure 32. Currents induced by co-expression of KCNE1 with WT or F279I Kv7.1 mutant channels. Currents
induced in COS7 cells transfected with Kv7.1 plus KCNE1 cDNA (A). For panels A-B, pulses were applied from a
holding potential of -80 mV to +100 mV in 20 mV steps. Tail currents were recorded at -50 mV. IV relationships
obtained after plotting the current magnitude at the end of 5.5 depolarizing pulses (C) or after measuring the
current at 300 ms (D). Voltage dependence of activation (E) Activation curves were obtained by plotting the tail
current versus the membrane potential normalized. Results show the mean±SEM of 8-9 cells per group.*P<0.05
vs.WT Kv7.1/KCNE1. 
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interaction between both subunits we performed coimmunoprecipitation experiments in HEK293 cells. As it is 
shown in Figure 33A, there were no differences in the co assembly between F279I Kv7.1 channels and KCNE1 
compared with the WT Kv7.1 channel. We also examined the effects of the point mutation F279I on the traffic of 
Kv7.1 protein using a cell surface biotinylation assay. These analyses revealed an increased surface expression 
of F279I Kv7.1 channels in HEK293 cells transfected cells in comparison to WT Kv7.1 channel (Figure 33B). 
There was no change in the protein expression levels of Kv7.1 channels as revealed by immunoblot analyses of 
the whole cell lysates (Figure 33). Analyses on Kv7.1 surface expression by biotinylation assay in the presence of 
KCNE1 reveal that F279I Kv7.1 channel gain of function is also mediated by an increase of its cell surface 
expression.  
 
 
4.3.6 Rate-dependent increase in current upon depolarizing pulse trains 
 
It has been shown that IKs is important for both action potential repolarization and adaptation to changes 
in rate (276-279). Action potential duration shortens in response to elevated heart rate, which is a necessary 
accommodation in order to maintain a proper time spent in electrical systole to time spent in diastole (280,281). 
Slow activation ensures that IKs activated by a single pulse (action potential) does not reach the maximal value 
and can be further increased. This increase in IKs appears to be the result of pooling channels in open and mostly 
pre-open states leading to a shorter delay in the activation and increased amplitude upon a subsequent 
depolarization (146,275). Since the F279I mutant resulted in faster activation kinetics, we investigated how these 
altered electrophysiological properties affected the rate dependent effects of IKs. To this end, we applied a 
stimulus train of 70 depolarizations to + 50 mV from a holding potential of -80 mV at different frequencies (1,2 and 
2.5 Hz) mimicking normal and fast heart rates. For the WT Kv7.1/KCNE1 channel complex, no increase in current 
was observed at 1 Hz, but at faster rates (2 Hz and 2.5 Hz) a significant increase was observed (Figure 34A). 
This corresponds well to previously described rate-dependencies for WT Kv7.1/KCNE1 (282). To quantify this 
increase, the instantaneous current amplitude of each pulse was normalized to the steady state current amplitude 
reached with a single 5.5 s depolarization to +50 mV. This normalized current was plotted as a function of cycle 
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number and displayed a clear increase in current with shorter cycle lengths. When the same stimulus waveform 
was applied to cells expressing F279I Kv7.1/KCNE1 channels there was a notable increase in current even at 1 
Hz. This indicated that the rate-dependent increase in current for the mutant F279I Kv7.1/KCNE1 channels 
occurred at every frequency and did not reach its maximum level (Figure 34B). Thus, the altered kinetics of the 
mutant might account for increased IKs especially at elevated heart rates. 
 
4.3.7 Heterozygous condition 
 
To mimic the heterozygous condition occurring in the patient, co-expressions of the WT and F279I Kv7.1 
mutant channels in a ratio (1:1) together with KCNE1 were performed. Figure 35A shows representative current 
traces. The WT/F279I Kv7.1/KCNE1 channel complexes, exhibited a faster activation kinetics compared with WT 
Kv7.1/KCNE1 (f 616±70 ms vs. 794±36 ms for WT/F279I Kv7.1/KCNE1 and WT Kv7.1/KCNE1 channel 
complexes, P<0.05, n=4-9) but slower than F279I Kv7.1 /KCNE1 (f 616±70 ms vs. 445±27 ms for WT/F279I 
Kv7.1/KCNE1 and F279I Kv7.1/KCNE1, P<0.05, n=4-8). Compared to WT Kv7.1/KCNE1 channels, the 
deactivation kinetics was faster for the heterozygous channel complex (Figure S5). The current amplitude for the 
heterozygous condition was also greater compared to WT Kv7.1/KCNE1 at the end of the 5.5 depolarizing pulse 
at potentials between 0 and +40 mV and at every potential positive to -20 mV when measured 300 ms after the 
Figure 34. Rate dependent current increase for WT and F279I Kv7.1/KCNE1 channels. Panel A shows current 
recordings for WT and F279I Kv7.1/KCNE1 channels. On the top, it is shown the train protocol used and the 
corresponding current at different frequencies (1, 2 and 2.5 Hz). To normalize this increase in current, the 
instantaneous current amplitude was normalized to the steady-state current amplitude reached during a 5.5s 
depolarizing pulse to +50 mV and plotted as a function of the pulse number (B). Results show the mean±SEM of 8-
9 cells per group. 
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first voltage step (P<0.05; n=4-9) exhibiting an intermediate phenotype (Figure 35C) . The activation curve for the 
heterozygous was shifted towards more negative potentials compared to WT Kv7.1/KCNE1 exhibiting an 
Figure 35. Electrophysiological properties of the heterozygous WT/F279 Kv7.1/KCNE1 channel complex.
Current induced in COS7 cells transfected with WT and F279I Kv7.1 plus KCNE1 cDNA. (A). Pulses were applied
form a holding potential of -80 mV to +100 mV in 20 mV steps. Tail currents were measured at -50 mV. Activation
curves were obtained by plotting the normalized tail current versus the membrane potential (B). IV relationships
obtained at the end of a 5.5 depolarizing pulse or after 300 ms (C). Rate dependent current increase for WT
Kv7.1/F279I Kv7.1/KCNE1 channels (D-E). The train pulse protocol applied was the same described in Figure x.
The heterozygous channel complex exhibited an intermediate phenotype between WT Kv7.1 current and WT
Kv7.1/KCNE1 current. Results show the mean±SEM of 4-9 cells per group. *P<0.05 vs. WT Kv7.1/KCNE1 
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intermediate phenotype between the F279I Kv7.1/KCNE1 and WT Kv7.1/KCNE1 channel complexes (Figure 
35B). Finally, the rate-dependence increase of IKs was analyzed. At low frequencies, a decrease in the normalized 
current was observed compared to WT Kv7.1/KCNE1were observed between the heterozygous and WT 
Kv7.1/KCNE1 channel complexes and a slower kinetic of increase. However, at 2.5 Hz the rate-dependent 
increase in current for the WT/F279I Kv7.1/KCNE1 complexes was higher than those induce by WT Kv7.1/KCNE1 
and it did not reach the steady-state as it was noticed for F279I Kv7.1KCNE1 channel complexes (Figure 36D-E). 
All these data indicate that co-expression of the WT Kv7.1 subunit together with the mutant F279I subunit 
mimicking the heterozygous inheritance, also results in a gain of function of IKs. 
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5.1 MODULATION OF Kv AND Kir CURRENTS BY 15-EPI-LIPOXIN-A4 IN 
ACTIVATED MACROPHAGES. IMPLICATIONS IN INNATE IMMUNITY 
 
This study provides experimental evidence for new mechanisms of action by which e-LXA4 contributes to 
inflammation resolution. On one hand, by directly attenuating NF-κB activity and, on the other hand, affecting the 
electrophysiological properties of the macrophage membrane. We have demonstrated that: 1) activation of 
BMDM with IL4/IL13 produces similar effects on potassium currents to those reported after glucocorticoid 
treatment; 2) when acutely administrated, e-LXA4 decreases Kv currents in LPS-stimulated BMDM, and also Kir 
currents in resting, LPS- and IL4/IL13-stimulated BMDM at potentials negative to -120 mV, suggesting receptor-
independent effects; 3) after prolonged exposure of BMDM to e-LXA4, the LPS-induced effects on Kv and Kir were 
partially reverted, at the same time that the enhanced protein levels of Kv1.3 and Kir2.1 were downregulated; 4) 
long term exposure to e-LXA4 reverted the LPS-induced calcium influx; and 5) the effects of e-LXA4 on Kv and Kir 
channels in LPS-activated BMDM were partially mediated via ALX receptor.  
 
Potassium channels play a critical role in maintaining the electrochemical gradient required for sustained 
calcium entry in the time frame required for activation and effector functions of immune cells (86). We previously 
reported that LPS-activated RAW 264.7 macrophages exhibited a 1.6-fold elevation in functional Kv1.3 channels 
vs. their non-stimulated counterparts (69). We also described that heteromeric Kv1.3/Kv1.5 channel expression 
and their biophysical and pharmacological properties changed differentially upon activation and 
immunosuppression: LPS induced Kv1.3 protein expression, whereas treatment with dexamethasone resulted in 
the opposite effect (69). This enhanced Kv1.3 expression is likely to promote calcium signaling necessary for co-
activation/effector functions of macrophages. Indeed, blockade of Kv1.3 channels suppresses antigen-driven 
proliferation and cytokine production in T cells, and ameliorate experimental allergic encephalomyelitis in rats 
induced by the adoptive transfer of myelin specific activated effectors memory T cells (283-286). Moreover, 
several groups have described that Kv1.3 is expressed in macrophages and microglia (67,69,287-292). Indeed, 
Kv1.3 channels, together with Kir2.1, Kv1.5, KCa3.1 and BKCa channels modulate macrophage and microglia 
function and therefore, immunotherapy with channels blockers may have effects on the immune response 
(67,288,293-295). Our data add new insights on the fine-tuning of these channels by lipoxins. 
 
The effects of e-LXA4 were analyzed in resting, LPS-stimulated (innate response) or IL4/IL13-stimulated 
(alternatively response) BMDM. In resting cells, the outward Kv current exhibited small amplitude, fast activation 
and very slow inactivation kinetics. Most of the Kv current seems to be due to the activation of heterotetramers of 
Kv1.5+Kv1.3 subunits in which Kv1.5 predominates (67,69). Under these conditions, e-LXA4 did not produce 
significant effects on the magnitude of the Kv current, the use-dependent decrease or the slow inactivation of the 
current. These results suggest that e-LXA4 does not produce significant direct effects on Kv1.5 channels, and 
experiments performed on stably transfected Ltk- cells expressing Kv1.5 channels confirmed it (data not shown). 
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As previously reported, LPS increases Kv and decreases Kir currents (63,67,69). The increase in Kv current 
induced by LPS appeared concomitantly with a use-dependent decay and a C-type inactivation, both 
characteristics of Kv1.3 channels. In agreement, LPS upregulated both the mRNA and protein levels of Kv1.3. On 
LPS-stimulated macrophages, e-LXA4 decreased the magnitude of the Kv current but did not modify the use-
dependent decrease or the C-type inactivation of the current. Thus, some of the effects of e-LXA4 in LPS-
stimulated cells are probably due to a direct interaction with the Kv1.3 channels. Finally, after stimulation of 
BMDM with IL4/IL13, Kv currents exhibited similar magnitude than those recorded in resting cells. Interestingly, 
although activation of BMDM with IL4/IL13 did not modify the amplitude of the current, it decreased the use-
dependent effects, resembling the actions of dexamethasone (69). These results suggest that alternative 
activation can change the stoichiometry of Kv, leading to the formation of channels with a decreased Kv1.3:Kv1.5 
ratio, which is supported by a slight increase in the mRNA for Kv1.5 after IL4/IL13 activation. In BMDM stimulated 
with IL4/IL13, e-LXA4 did not produce significant effects on the magnitude nor the electrophysiological properties 
of Kv currents. In resting and alternatively activated BMDM, Kir current exhibited the typical characteristics of the 
inward rectifying potassium current. As it was previously reported, LPS decreased Kir current, consistent with a 
downregulation of the mRNA for Kir2.1 (67). e-LXA4 decreased the amplitude of the Kir current at negative 
membrane potentials under the three experimental conditions tested. In resting BMDM, but not in LPS- or 
IL4/IL13-stimulated BMDM, the reversal potential became more positive, which leads to a depolarization of the 
membrane potential, thus avoiding Ca2+ entry into the cell.  
 
Since the early inhibitory effects of e-LXA4 on NF-κB and pro-inflammatory signaling are extended at later 
periods (>10h), the electrophysiological effects of long-term incubation with e-LXA4 were studied. Long term treatment 
with e-LXA4 did not modify the magnitude of the Kv or the Kir currents in resting BMDM. On the contrary, it was able to 
partially prevent the electrophysiological effects produced by LPS, decreasing the amplitude, the use-dependent 
decrease and the C-type inactivation of the Kv current. In a parallel way, chronic e-LXA4 diminished the decrease of 
the Kir current induce by LPS. Using the selective inhibitor of ALX, BocPLP (254) we have shown that the actions of 
long term incubation with e-LXA4 on Kv currents are, at least in part, dependent on the interaction with ALX 
receptor. Indeed, in LPS-stimulated BMDM, Kv1.5 protein level was not modified by e-LXA4, whereas Kv1.3 was 
upregulated by LPS and downregulated by e-LXA4. Since Kv currents recorded in BMDM stimulated with LPS are 
the consequence of the activation of heterotetramers of Kv1.5+Kv1.3 with different stoichiometry, the contribution 
of Kv1.5 to the total of this current can explain the apparently low dependency of the effects of e-LXA4 on Kv. On 
the contrary, the Kir current measured in the presence of BocPLP in cells treated with e-LXA4+LPS was much 
more similar to that recorded in BMDM activated with LPS, suggesting that the e-LXA4 effects on Kir channels 
involves the interaction with the ALX receptor. The influx of extracellular Ca2+ is an essential requirement for the 
activity of many cellular processes (84,235,296). Therefore, Kv1.3 channels and the Ca2+-activated K+ channel 
KCa3.1 regulate Ca2+ influx through the calcium release activated Ca2+ channel, which consists of the Ca2+-sensor 
stromal interaction molecule 1 (STIM1) and the pore-forming protein CRACM1 (Orai1) (244,245,297,298). In T 
cells, this crucial influx of Ca2+ is only possible if they can keep its membrane potential negative by a 
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counterbalance of K+ efflux through Kv1.3 and/or KCa3.1 (86,299) and both channels are regarded as targets for 
immunosuppression (86). In the present study, we have demonstrated that e-LXA4 inhibits Kv1.3 in LPS-
stimulated cells. This inhibition would lead to a depolarization of the membrane potential and, as a consequence, 
to an inhibition of the Ca2+ influx through CRAC channels, which is a critical event in the activation of 
macrophages (300). Indeed, we have reported that in cells activated with LPS, e-LXA4 is able to decrease 
extracellular entry of Ca2+. Therefore, e-LXA4 may produce its antiinflammatory effects through this new 
mechanism of action. 
 
Lipoxins were the first mediators exhibiting both antiinflammatory and proresolving actions. The 
beneficial actions of aspirin in the cardiovascular system have been attributed to its capability to block 
prostaglandin and prothrombotic thromboxane (TXA2) generation via acetylation of COX. Aspirin acetylation of 
COX-2 not only inhibits prostanoid formation but also alters the active site of COX-2 and thereby permits 
conversion of arachidonic acid into 15R-HETE in vascular endothelial cells. This intermediate compound can be 
further transformed to epimeric lipoxins by leukocytes and other immune cells contributing to the fine tuning of the 
inflammatory response. Our data describe a direct inhibition of e-LXA4 on IKKβ activity, a broad inhibition of NF-
κB activity and a cytoprotective mechanism of macrophages during resolution. In addition to this, Ca2+ fluxes are 
negatively modulated by e-LXA4 through the inhibition of Kv1.3 channels in LPS-stimulated cells; all these 
mechanisms concur on the attenuation of the inflammatory response as far as e-LXA4 accumulates in the 
medium. 
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5.2 EFFECTS OF n-3 PUFAs ON Kv7.1/KCNE1 CURRENT 
 
In this section of the present Doctoral Thesis we have investigated the effects of EPA and DHA, two n-3 
PUFAs from marine origin on Kv7.1/KCNE1 channels expressed in COS7 cells. We have demonstrated that: 1) At 
physiological concentrations, both PUFAs increase the magnitude of Kv7.1/KCNE1 current after acute but not 
after chronic exposition, DHA being more potent than EPA. 2) Acute and chronic effects of PUFAs were time- and 
voltage-dependent. 3) Both PUFAs reduced the expression of Kv7.1, but not that of KCNE1 due to an enhanced 
degradation of Kv7.1 via proteasome. 4) Both PUFAs delocalized Kv7.1 channels from lipid rafts and 5) EPA 
effects on Kv7.1/KCNE1 current recorded in cholesterol depleted cells were similar to those observed after acute 
exposition, consistent with a direct interaction with the channel. 
 
In this study we have demonstrated that acute perfusion of EPA or DHA increased to a different extent 
the magnitude of Kv7.1/KCNE1 current. However, their effects on the electrophysiological properties of this 
current exhibited some differences. Thus, EPA increased Kv7.1/KCNE1 current in a time- and voltage-dependent 
manner. The midpoint of the activation curve in the presence of EPA was shifted towards more negative 
membrane potentials and the increase in the magnitude of the current was also voltage dependent, being greater 
at 0 than at +60 mV. EPA slowed the activation time course and speeded up the deactivation process. This 
slowing of the activation time course was due to an increased contribution of the slow component of activation to 
the total process, and not to changes in the time constants. Therefore, EPA effects on the activation kinetics can 
be the consequence, at least in part, of the shift in the activation curve. On the other hand, DHA increased the 
Kv7.1/KCNE1 current to a greater extent than EPA in a time-dependent but voltage-independent manner: The 
midpoint of the activation curve was not modified in the presence of DHA. DHA slowed the total process of 
activation but to a lesser extent than EPA, despite it accelerated the initial fast component of activation. Similarly 
to EPA, DHA accelerated the deactivation kinetics. As previously described, neither EPA nor DHA modified the 
properties of Kv7.1 channels when expressed alone. Thus, the presence of KCNE1 subunits is essential for the 
observed electrophysiological effects of acutely applied PUFAs. 
 
Dietary administration of fish oil leads to the incorporation of n-3 PUFAs into the cell membrane including 
membranes from myocytes of the heart (213,301). During the last decade, it has been reported that long term n-3 
PUFAs intake also modulate the activity of several cardiac ion channels. However, the effects of long term 
administration of n-3 PUFAs on several ion currents in some cases differ from those observed by acutely 
administered n-3 PUFAs (302). When acutely applied, n-3 PUFAs decrease INa (207,214,303-305) ICa,L (208), ITo 
(210,306,307), IKur (206,212) and IKr (211), whereas when chronically applied they have no effect on INa, (195,213) 
ITo, (213) and IKr (213) but decrease ICa,L (213) and IKur (212). According to this, when the effects of long term 
administration of EPA (48 h) on COS7 cells expressing Kv7.1/KCNE1 channels were analyzed, we observed 
some differences compared to the effects produced by acute perfusion with the fatty acid. Chronically applied 
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EPA did not increase the current magnitude; however, it accelerated the activation process and, surprisingly, 
shifted the activation curve towards more positive potentials, suggesting that the mechanism by which acute or 
chronic n-3 PUFAs modulate the electrophysiological properties of Kv7.1 channels is different. 
 
Several hypothesis have been proposed to explain the electrophysiological differences between acute 
and of long term administration of n-3 PUFAs. Some authors explain n-3 PUFAs effects by a direct interaction 
between n-3 fatty acid and the ion channel. This hypothesis is supported by the observation that substitution of a 
single amino acid in the human Nav1.5 channel diminished the inhibitory effect of acutely administered EPA 
(304).The results from this Doctoral Thesis showing that such similar compounds (EPA and DHA) exert different 
effects on Kv7.1/KCNE1 current, are in agreement with a direct interaction between the n-3 PUFA and the ion 
channel, at least when they are acutely applied. However, other authors suggest that n-3 PUFAs effects are the 
result of an alteration of the membrane properties rather than a direct interaction with the ion channel. It has been 
reported that n-3 PUFAs alter the composition and order of the plasmalema (302). In this line of evidence, it has 
been proposed that the potency of n-3 PUFAs to block cardiac sodium currents is correlated with their ability to 
increase membrane fluidity measured by steady-state fluorescence anisotropy (308). In addition to these two 
mechanisms, changes in cellular redox status, metabolism of phospholipids and modulation of gene expression 
are other processes in which n-3 PUFAs participate that might modulate ion channel function (309).  
 
In order to further explore the mechanisms by which acute and chronic n-3 PUFAs exert their actions on 
Kv7.1/KCNE1 channels, three different approaches were used: The effects of long-term administration of EPA 
were analyzed on: 1) Kv7.1 and KCNE1 expression, 2) their target to lipid rafts, and finally, 3) the effects of 
cholesterol depletion with MCD on Kv7.1/KCNE1 current followed by the acute application of EPA on cholesterol 
depleted cells.  
 
In addition to their ability to modulate the electrophysiological properties of ion channels, it has been 
reported that n-3 PUFAs can modify their protein levels as was the case of Kv1.5 (212). Our data showed that 
long term administration (48 h) of n-3 PUFAs also decreased the protein levels of Kv7.1, but not those of KCNE1, 
in a concentration-dependent manner. It was established that one mechanism that modulates Kv7.1 protein 
stability involves its ubiquitination by the Nedd4-2 ubiquitin ligase and posterior degradation in the proteasome 
(268). Since this decrease was prevented by the MG132 proteasome inhibitor; these data suggest that n-3 
PUFAs promote Kv7.1 degradation via proteasome.  
 
Kv7.1 channels target lipid rafts in eukaryotic cells, whereas KCNE1 does it only when Kv7.1 subunit is 
present (269). Cell incubation with EPA delocalized both Kv7.1 and KCNE1 subunits. On the contrary, DHA 
induced a delocalization of Kv7.1 channels from these membrane structures, whereas KCNE1 remained targeted 
to lipid rafts. It has been proposed that ion channels located in lipid rafts form signaling complexes and that they 
represent the locus of the cell membrane in which the ion channel, regulatory subunits, scaffolding proteins, 
   Discussion 
79 
kinases and other modulatory proteins interact (310). Differential targeting of Kv7.1 and KCNE1 subunits to lipid 
rafts represents an important mechanism that regulate this current properties as it has been described for several 
ion channels (270,311-316). 
 
The importance of Kv7.1 and KCNE1 location on specific microdomains for their function was confirmed 
in experiments in which lipid rafts structures were disrupted. Our results showed that membrane cholesterol 
depletion with MCD and, consequently, lipid raft disruption, markedly increased the current magnitude of 
Kv7.1/KCNE1 at potentials positive to +30 mV and shifted the activation curve towards more positive potentials. 
Although the current magnitude did not increase after incubating COS7 cells with EPA for 48 h, the shift of the 
activation curve was very similar to that obtained after MCD treatment. Hence, at least some of the 
electrophysiological changes on Kv7.1/KCNE1 current might be due to a different location of both subunits on the 
plasma membrane induced by the chronic treatment with the fatty acid. The precise mechanism involved in lipid 
raft modulation of channel activity is not fully understood. Three different explanations have been proposed: i) by 
affecting the biophysical properties of the membrane. Because of its high content on cholesterol and 
sphingolipids, lipid rafts represent thicker and less fluid parts of the membrane than nonrafts domains. Changes 
in the membrane fluidity may modulate ion channel activity through a hydrophobic mismatch between the 
transmembrane domains of the protein and the lipid bilayer. According to this, it has been described that TRPM8 
channels agonists, such as menthol, geraniol and monoterpenes enhance the membrane fluidity and increase the 
ion current (270). Conversely, increasing the order of the membrane after enrichment with cholesterol inhibits 
Kv11.1 and Kv7 currents (315). We can speculate that the location of Kv7.1 and KCNE1 subunits in a thicker and 
less deformable membrane will increase the energy required for the transition from the closed to the open state. 
ii) By specific lipid-protein interactions occurring at rafts microdomains. A growing number of studies have 
demonstrated that cholesterol and PIP2, major components of the lipid rafts, modulate the activity of several ion 
channels (103,111,150). Supporting this hypothesis it was described that an increase in cholesterol strongly 
suppresses Kir2.1 current (317). In fact, point mutations on specific region of the C-terminus of the cytosolic 
domain of the channel, called CD-loop, abrogated the sensitivity of Kir2 channels to cholesterol (317). Moreover, it 
has been recently reported the binding site for fatty acids in the cavity of the prokaryotic potassium channel KcsA 
(318). iii) By protein-protein interactions. It is known that lipid rafts are enriched in multiple signaling molecules 
such as G-proteins, protein kinases, phosphatases, Ca2+ binding proteins, etc. Lee and co-workers reported that 
inhibition of Kv7 channels by cholesterol involves the activity of PKC. Following a similar reasoning, the interaction 
between Kv7.1/KCNE1 with adjacent proteins could destabilize the closed conformation of the ion channel within 
less ordered domains of the membrane than lipid rafts. It is important to note that these mechanisms are not 
mutually exclusive. Finally, in cholesterol depleted cells, posterior perfusion with EPA produced similar effects on 
Kv7.1/KCNE1 current than those observed in acute conditions. EPA slowed the activation kinetics and increased 
the magnitude of the current at potentials negative to +30 mV. These effects were reversible when cells were 
washed with EPA-free external solution. The functional analysis from our data in cells lacking lipid rafts domains 
revealed two different effects of EPA on Kv7.1/KCNE1. Compared with acute EPA, a very similar pattern of 
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current increase (higher at negative potentials) and a change in the slope factor of the activation curve, which 
was fully reversed, were observed. This fact strongly suggests a direct interaction between the fatty acid and the 
channel protein. On the other hand, after MCD treatment, EPA was not able to shift the activation curve toward 
more negative potentials indicating that other mechanisms such as specific protein-protein interactions or the 
composition of the lipid environment could be also involved in the modulation of Kv7.1+KCNE1 by PUFAs. 
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5.3 A NEW MUTATION ON KV7.1 RESPONSIBLE OF SHORT QT SYNDROME 
 
As mentioned before, Kv7.1 is the alpha subunit of the ion channel complex underlying the slow 
component of the cardiac delayed rectifier IKs (135,136). IKs, together with IKr, are the major repolarizing currents 
of ventricular myocytes (257). Gain of function mutations on Kv7.1 cause QT shortening and thus, the type 2 short 
QT syndrome. Until date, three mutations associated with short QT2 have been found: two located in the S1 and 
another one in the S6 transmembrane segment of Kv7.1. In this Doctoral Thesis we have characterized the 
functional effects of the new missense mutation F279I on Kv7.1 found in a patient with a QTc interval of 356 ms at 
resting and a family history of SCD. This mutation, located in the S5 transmembrane segment, modifies the 
gating of WT Kv7.1/KCNE1 complexes. As it is shown in Figure 29, among the Kv7 family, and also in other 
potassium channels, Kv7.1 is the unique channel carrying a phenylalanine at the equivalent position; suggesting 
that this residue might be important for the exceptional properties of the cardiac IKs 
 
The mutant F279I Kv7.1 channel compared with WT Kv7.1, showed a slower activation kinetics and a 
reduced degree of inactivation, a characteristic that is exclusively observed in the absence of KCNE1 (140). Tail 
currents decay of WT Kv7.1 channels were preceded by a relatively rapid increase, due to recovery of channels 
from an inactivated state. In contrast, deactivation currents of F279I Kv7.1 were not preceded by any increase. 
The lack of the initial hook in the tail current suggested that mutant channels did not inactivate at potentials as 
positive as +80 mV. This was confirmed using a three-pulse protocol designed to determine the degree of 
inactivation. These experiments confirmed that F279I Kv7.1 channels inactivated to a lesser extent than WT Kv7.1 
channels at every potential tested. Structural basis of Kv7.1 for inactivation is not fully understood, but several 
reports indicate that mutations in the S5, were the F279I lies, have a profound effect on the voltage dependence 
of this process (125,144,319) and therefore, on the channel gating. 
 
Co-assembly of F279I Kv7.1 with KCNE1 had a big impact on Kv7.1/KCNE1 current properties. The 
functional effects of KCNE1 are to modulate Kv7.1 kinetics (slower activation and slightly slower deactivation), to 
remove inactivation (135,136) and to increase current magnitude by enhancing the single channel conductance 
(121,127,128). Compared with Kv7.1/KCNE1, the F279I Kv7.1/KCNE1 current exhibited faster activation kinetics, 
increased current magnitude at potentials between -20 and 20 mV, and a more negative midpoint for activation. 
In addition, it showed a small degree of inactivation, revealed by the fact that F279I Kv7.1/KCNE1 reached the 
steady state at potentials positive to +80 mV. Therefore, the electrophysiological properties of the F279I 
Kv7.1/KCNE1 current seem to be intermediate between Kv7.1 and Kv7.1/KCNE1 current. Taken together, all 
these results suggest that the underlying mechanism by which this mutation modifies the gating of F279I 
Kv7.1/KCNE1 current seem to be due to an abnormal interaction of F279I Kv7.1 with the accessory KCNE1 
subunit. All these effects lead to a gain of function, which likely will result in an enhanced IKs repolarizing current 
during the AP. 
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The interaction between KCNE1 and Kv7.1 appears to involve interactions between residues located 
extracellularly (320,321), specific elements in the intracellular C-termini regions (282) and residues in the 
transmembrane segments (322-325). These data argue for a multi-point interaction between KCNE1 and the 
voltage sensing and pore-domain of neighboring Kv7.1 subunits (326). Furthermore, it appears that these 
interactions are dynamic and that KCNE1 reorients with respect to Kv7.1 during channel gating (320,321). 
According to this hypothesis, there have been reported three substitutions on Kv7.1 located in close proximity to 
279 residue (L266W, F275W, and Y278A) and another one at the exact position of the mutation of the present 
suty but to a different amino acid F279A, which impaired KCNE1 modulation of channel gating. Mapping these 
residues onto the Kv1.2 structure shows that F275, F278 and F279 are located at the interface between the 
voltage-sensor and the pore domain. It is possible that the interaction sites between KCNE1 and the pore region 
of Kv7.1 are state-dependent. KCNE1 transmembrane domain most likely undergoes cooperative movement 
upon channel opening. As a consequence, different residues in S5 are closer to the neighboring KCNE1 subunit 
at the closed and open states. KCNE1 is most likely in close contact with L266 at the closed state, whereas F275, 
Y278, F279 at the open state. Since these mutations do not affect Kv7.1 gating properties when expressed alone, 
this study together with the results presented in the present Doctoral Thesis suggest that these residues are 
determinant for Kv7.1-KCNE1 interaction. F279I Kv7.1 mutation results in a substitution of a phenylalanine for an 
isoleucine. Both aminoacids are hydrophobic, however, the former is larger and posses an aromatic ring that 
could establish - interactions with another aminoacids carrying an aromatic ring (Phe, Tyr and Trp). Therefore, 
we can speculate that a larger amino acid or an aromatic ring is necessary to achieve a correct interaction 
between the alpha and the beta subunits. In fact, and supporting this hypothesis, it was reported that replacement 
of the phenylalanine by a tryptophan at the same position induced the opposite effect, a shift of the activation 
curve towards more positive potentials. In addition to these findings, biotinylation assays showed an increased 
protein expression of F279I compared to WT Kv7.1 channels on the cell membrane. However, it has been 
suggest that KCNE1 subunit would probably directly interact with the S6 segment of Kv7.1 channels but not with 
the S5 segment. Then, the effects of al these mutations at the S5 on the electrophysiological properties of Kv7.1 
might be due to an impaired coupling of the gating modulation of Kv7.1 induced by KCNE1 and not to an altered 
physical interaction with the β subunit. 
 
An enhanced translocation of Kv7.1 channels to the membrane would predict an increased current 
density that correlates with the electrophysiological analysis of our data and again points out to a gain of function 
of Kv7.1/KCNE1 current when the complexes incorporate F279I Kv7.1 subunits. 
 
It has been shown that the contribution of IKs to repolarization is rate dependent (276,277). At slow heart 
rates, there is no accumulated activation of IKs because diastole is sufficiently long to allow for complete 
deactivation. As heart rate speeds up, the diastolic interval becomes shorter and the deactivation of IKs is 
incomplete between beats. This results in an accumulation of the channels in the pre-open closed states, which 
leads to a rate-dependent increase of current, which causes action potential shortening (146,275). To compare 
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the effects of repetitive stimulation between WT Kv7.1/KCNE1 and F279I Kv7.1/KCNE1 channels train pulses at 
variable cycle lengths in order to simulate a condition of rest (1 Hz) and exercise (2 Hz, 2.5 Hz). Even at 1 Hz, the 
F279I Kv7.1/KCNE1 channel complex already displayed steady-state current amplitude that was larger compared 
to WT Kv7.1/KCNE1. At every frequencies(1 Hz, 2 Hz and 2.5 Hz), the overall current amplitude was also higher 
compared to WT and, importantly, it did not reach the steady state. All these data suggest that the enhanced 
accumulation of activation of IKs in response to increased heart rate would be more pronounced in F279I 
Kv7.1/KCNE1 channels, likely because its activation kinetics is faster and its deactivation kinetics slower and 
hence will exhibit a different response to changes in rate. 
 
Since patients are heterozygous for the F279I mutation, co-expression experiments of the WT and F279I 
Kv7.1 together with KCNE1 were performed to mimic the in vivo situation. The voltage dependence of activation 
for WT/F279I Kv7.1/KCNE1 was intermediate to those of WT Kv7.1/KCNE1 and F279I Kv7.1/KCNE1 complexes, 
as it was the activation kinetics and the current magnitude. As mentioned before, these biophysical 
characteristics would point out to an enhanced function of the heterozygous channel complex. Regarding to the 
rate-dependent effects, it was observed that at slow rates (1-2 Hz), there were no differences compared with the 
WT Kv7.1/KCNE1 situation. However, at faster rates (2.5 Hz), although there was just a slight increase in the 
accumulation of current, it did not reach the steady state, as the WT Kv7.1/KCNE1 complex did. Taken together, 
the results of our experiments are indicative of a significantly greater contribution of IKs to net AP repolarization 
when WT Kv7.1/KCNE1 channels complexes incorporate F279I Kv7.1 subunits  
 
There is little information in the literature on the short QT syndrome, and this is based on small series of 
cases or isolated case reports. Recently, a revision of 61 cases has set the QTc cut-off for the diagnosis of the 
syndrome in 370 ms, although variability of this interval in different ECGs from the same patients varied 
significantly and in 2 cases the interval was constantly above this value (188). Compared to long QT and Brugada 
syndrome, there is no drug challenge test to help in the diagnosis. Both the son and the daughter of the index 
case were carriers of the F279I Kv7.1 mutation. A recent study from Schimpf and colleagues analysed the 
response of the QTc on exercise in patients with short QT syndrome compared to a control group (327). QTc of 
normal individuals in this study shortened to a greater extent the QTc more than short QT syndrome patients 
(327). The patient showing F279I mutation had a baseline ECG QTc of 356 ms and shortened with exercise up to 
350 ms.  
 
According to short QT syndrome diagnostic criteria (188), to begin to implement the diagnostic algorithm 
the QTc interval has to be shorter than 370 ms. The patient had a QTc interval of 356 ms (1 point), a Jpoint-T 
peak interval of 144 ms (no point), a first-degree relative with autopsy-negative who suffered SCD (1 point), and 
after the electrophysiological characterization of the F279I Kv7.1 realized in the present study, a genotype positive 
(2 points). Within this criteria, the patient would obtained in summary 4 points (high probability of short QT). 
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Although the present study does not definitely prove an association between the short QT interval and 
the Kv7.1 mutation, our data provide clear evidence for a causal relationship based on several findings. This 
residue is unique among the equivalent amino acid in the Kv7 family, and it appears to be an important residue for 
the Kv7.1-KCNE1 interaction. The electrophysiological characteristics associated with the mutation are expected 
to lead an enhanced repolarization with shortening of the QT interval (leftward shift of the activation curve, faster 
activation kinetics, and increased accumulation of current in response to changes in rate). F279I Kv7.1 protein 
expression is enhanced compared to WT, which further contribute to the increased repolarization of IKs when 
channels incorporate F279I subunits. And finally, no additional mutation was found among the genes that might 
be responsible of the short QT phenotype. 
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1. e-LXA4 contributes to inflammation resolution by directly attenuating NF-κB activity and affecting the 
electrophysiological properties of the macrophage. e-LXA4 partially reverts the effects produced by LPS 
on Kv and Kir currents in BMDM. In addition, Ca2+ fluxes are negatively modulated by e-LXA4 in LPS-
stimulated cells. All these mechanisms converge in the attenuation of the inflammatory response. 
 
2. The effects of n-3 PUFAs on Kv7.1/KCNE1 current depend on their way of administration. EPA and DHA 
increase Kv7.1/KCNE1 current magnitude when acutely applied. However, after long term incubation of 
cells expressing Kv7.1/KCNE1 with EPA, the magnitude of the current was not modified, although the 
kinetics and voltage-dependent characteristics were changed. The electrophysiological effects of acute 
EPA seem to be due to a direct interaction with the Kv7.1/KCNE1 channels. However, the modulation of 
Kv7.1/KCNE1 channels after chronic incubation with EPA seems to be due mainly to a delocalization of 
Kv7.1 channels from lipid rafts.  
 
3. The functional analysis of the novel F279I mutation in Kv7.1 provide clear evidence for a causal 
relationship for the appearance of short QT syndrome. The electrophysiological characteristics 
associated with the mutation are expected to lead to an enhanced repolarization with shortening of the 
QT interval: leftward shift of the activation curve of Kv7.1/KCNE1 channels, faster activation kinetics, and 
an impaired adaptation to change in response to changes in rate. Presumably due to an impaired gating 
modulation of Kv7.1 induced by KCNE1. 
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1. La e-LXA4 contribuye a la resolución de la inflamación directamente atenuando la actividad de NF-κB y 
afectando a las propiedades electrofisiológicas de los macrófagos. La e-LXA4 revierte parcialmente los 
efectos producidos por el LPS en las corrientes Kv y Kir de BMDM. Además, los flujos de Ca2+ en las 
células estimuladas con LPS están regulados negativamente por la e-LXA4. Todos estos mecanismos 
convergen en la atenuación de la respuesta inflamatoria. 
 
2. Los efectos de los AGPIs n-3 en la corriente Kv7.1/KCNE1 dependen del modo de administración. EPA 
y DHA aumentan la magnitud de la corriente Kv7.1/KCNE1 cuando son administrados agudamente. Sin 
embargo, tras la incubación prolongada de células que expresan Kv7.1/KCNE1 con EPA, la magnitud de 
la corriente no se modificó, a pesar de que las características cinéticas y dependientes de voltaje 
cambiaron. Los efectos electrofisiológicos agudos de EPA parecen estar debidos a una interacción 
directa con los canales Kv7.1/KCNE1. Sin embargo, la modulación de los canales Kv7.1/KCNE1 tras la 
incubación prolongada con EPA parece estar debida principalmente a una deslocalización de los 
canales Kv7.1 de las balsas lipídicas. 
 
3. El análisis funcional de la nueva mutación F279I de Kv7.1 proporciona evidencias claras de una relación 
causal para la aparición de síndrome de QT corto. Las características electrofisiológicas de la mutación 
producirían una repolarización aumentada y un acortamiento del intevalo QT: desplazamiento hacia la 
izquierda de la curva de activación de los canales Kv7.1/KCNE1, cinética de activación más rápida y 
una adaptación a los cambios en frecuencia alterada. Presumiblemente debido a una modulación del 
gating de Kv7.1 inducido por KCNE1 alterada. 
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Figure S1. Acute effects of e-LXA4 on Kir currents and degree of Kir inactivation. Representative traces of Kir
currents recorded in control, LPS and IL4/IL13 activated BMDM. BMDM were not stimulated (A) treated with LPS (100
ng/ml) (B) or IL4/IL13 (20 ng/ml) for 18h (C). Current recordings were obtained in the absence and after perfusion with
e-LXA4 (500 nM) (A-C). Currents were elicited by applying hyper- and depolarizing pulses from a holding potential of -
80 mV to different voltages from -140 to -40 mV in 10 mV steps (500ms duration). IV relationships in the absence and
in the presence of e-LXA4 (500 nM) in resting BMDM (D), or LPS (E) and IL4/IL13 (F) activated BMDM are shown. The
degree of Kir inactivation was determined under these conditions (G). Data are expressed as the mean ± SEM. *P<0.05
vs. control; n>10 cells per group (Student’s t test). 
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Figure S2. Voltage-dependent effects of acute DHA on Kv7.1/KCNE1 channels. (A) Currents were elicited 
in 10-mV increments to test potentials ranging from -80 to +60 mV from a holding potential of −80 mV in the 
absence and in the presence of DHA. (B) IV relationship obtained under control conditions and after perfusion
with DHA. (C) Activation curves obtained under control conditions and after perfusion with DHA. Peak tail 
currents were measured, and the normalized data were fit to a Boltzmann function. The midpoint for the
activation curve was Vmid=29.9±6.4 and 26.4±6.9 and the slope factor s=14.2±1.1 and 16.6±0.7 in the absence 
and the presence of DHA respectively (P>0.05, n=5) (D) Graph showing the ratio between the current obtained 
in the presence of DHA and that under control conditions. 
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Figure S3. DHA decreases steady-state levels of Kv7.1 protein. (A): Left: Shown are representative
western blots that illustrate treatments with DHA. Note that DHA induces dose-dependent reductions of Kv7.1
protein. Cellular lysates were prepared from COS7 cells transiently expressing Kv7.1 and incubated for 48h
with DHA at two concentrations (30 and 100 μM). Cellular lysates were prepared from COS-7 cells
transiently expressing Kv7.1 incubated with DHA. Samples were subjected to SDS-PAGE, transferred to
PVDF and probed with an antibody raised against Kv7.1. Right: Bar graph summarizing densitometry
measurements used to compare protein levels for the treatments of DHA for 48 h. β-actin levels were used
as a loading control (n=3 or 4; *:P<0.05). (B): Representative western blots and graph showing the effects of
DHA (0, 30 and 100 µM) on KCNE1 in cells transfected with Kv7.1+KCNE1). (C): Representative western
blots and graph showing the effects of DHA (0, 30 and 100 µM) on Kv7.1 in cells transfected with Kv7.1 or
Kv7.1+KCNE1 in the presence of MG132 (proteosome inhibitor.*P<0.05, n=3-4) 
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Figure S4. Effects of long term administration of DHA on Kv7.1 and KCNE1 location. Sucrose density gradient fractions 
of cells expressing Kv7.1 and KCNE1 in the absence or the presence of DHA. While caveolin indicated floating lipid rafts with
low density, clathrin labeled non-raft fractions. Kv7.1 and KCNE1 colocalized with caveolin in low-buoyant density fractions 
(fractions 2-6) in control experiments, whereas DHA triggered a wider distribution of proteins (fractions 1-12) and rafts. 
Pictures are representative images of at least 3 independent lipid rafts extractions analysed by western blot.  
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Table S1A. Time-dependent effects of acute EPA in cholesterol depleted cells on the activation 
process of Kv7.1/KCNE1 channels. Currents were recorded for each experimental condition after applying 
a 12s depolarizing pulse at +60 mV and were fitted to a biexponential function or to a monoexponential 
function in the case of EPA. (P>0.05, n=4, vs. the control condition, P>0.05, n=4, MβCD vs. MβCD). 
Activation kinetics 
CONTROL MβCD 10 mM EPA 20 µM MβCD 10 mM 
f (ms) s (ms) f (ms) s (ms) f (ms) f (ms) s (ms) 
863±66 7296±1370 1065±186 5951±1324 7329±1696  928±76 5715±170 
 
 
Table S1B. Time-dependent effects of acute EPA in cholesterol depleted cells on the deactivation 
process of Kv7.1/KCNE1 channels. Tail currents were recorded for each experimental condition at -40mV 
pulses after a depolarizing pulse to +60mV of 5.5s in duration and were fitted to a monoexponential function 
or a biexponential function in the case of EPA. (*P<0.05, n=4, vs. the control condition, P>0.05, n=4, MβCD 
vs. MβCD). 
Deactivation kinetics 
CONTROL MβCD 10 mM EPA 20 µM MβCD 10 mM 
 (ms)  (ms) f (ms) s (ms)  (ms) 
584±89 272±45* 144±14 439±89 232±34* 
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Figure S5. Comparison of deactivation time constants for the WT Kv7.1 channels expressed with the 
accessory subunit KCNE1 and for F279I Kv7.1/KCNE1 and WT/F279IKv7.1/KCNE1 channel complexes. 
Deactivation time constants were obtained by fitting the tail currents to monoexponential decay functions and 
were plotted as a function of the repolarization potential. (*P<0.05, n=4-11, for WT/F279IKv7.1/KCNE1 vs. the 
control condition). 
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9.1 Original papers 
 
Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action 
potentials 
Macías A*, Moreno C*, Moral-Sanz J, Cogolludo A, David M, Alemanni M, Pérez-Vizcaíno F, Zaza A, Valenzuela 
C, González T. (* Both authors contributed equally to this work) 
Abstract: Celecoxib is a COX-2 inhibitor that has been related to an increased cardiovascular risk and that exerts 
several actions on different targets. The aim of this study was to analyze the effects of this drug on human 
cardiac voltage-gated potassium channels Kv involved on cardiac repolarization Kv1.5 (IKur), Kv4.3+KChIP2 (Ito1)) 
and Kv7.1+KCNE1 (IKs) and to compare with another COX-2 inhibitor, rofecoxib. Currents were recorded in 
transfected mammalian cells by whole-cell patch-clamp. Celecoxib blocked all the Kv channels analyzed and 
rofecoxib was always less potent, except on Kv4.3+KChIP2 channels. Kv1.5 block increased in the voltage range 
of channel activation, decreasing at potentials positive to 0 mV. The drug modified the activation curve of the 
channels that became biphasic. Block was frequency-dependent, increasing at fastest frequencies. Celecoxib 
effects were not altered by TEAout in R487Y mutant Kv1.5 channels but the kinetics of block were slower and the 
degree of block was smaller with TEAin, indicating that celecoxib acts from the cytosolic side. We confirmed the 
blocking properties of celecoxib on native Kv currents from rat vascular cells, where Kv1.5 are the main 
contributors (IC50≈ 7 μM). Finally, we demonstrate that celecoxib prolongs the action potential duration in mouse 
cardiac myocytes and shortens it in guinea pig cardiac myocytes, suggesting that Kv block induced by celecoxib 
may be of clinical relevance. J Mol Cell Cardiol. 2010 Dec;49(6):984-92.  
 
Protein kinase C (PKC) activity regulates functional effects of Kvβ1.3 subunit on Kv1.5 channels: 
identification of a cardiac Kv1.5 channelosome 
David M, Macías Á, Moreno C, Prieto Á, Martínez-Mármol R, Vicente R, González T, Felipe A, Tamkun MM, 
Valenzuela C. 
Abstract: Kv1.5 channels are the primary channels contributing to the ultrarapid outward potassium current (IKur). 
The regulatory Kvβ1.3 subunit converts Kv1.5 channels from delayed rectifiers with a modest degree of slow 
inactivation to channels with both fast and slow inactivation components. Previous studies have shown that 
inhibition of PKC with calphostin C abolishes the fast inactivation induced by Kvβ1.3. In this study, we investigated 
the mechanisms underlying this phenomenon using electrophysiological, biochemical, and confocal microscopy 
approaches. To achieve this, we used HEK293 cells (which lack Kvβ subunits) transiently cotransfected with 
Kv1.5+Kvβ1.3 and also rat ventricular and atrial tissue to study native α-β subunit interactions. 
Immunocytochemistry assays demonstrated that these channel subunits colocalize in control conditions and after 
calphostin C treatment. Moreover, coimmunoprecipitation studies showed that Kv1.5 and Kvβ1.3 remain 
associated after PKC inhibition. After knocking down all PKC isoforms by siRNA or inhibiting PKC with calphostin 
C, Kvβ1.3-induced fast inactivation at +60 mV was abolished. However, depolarization to +100 mV revealed 
Kvβ1.3-induced inactivation, indicating that PKC inhibition causes a dramatic positive shift of the inactivation 
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curve. Our results demonstrate that calphostin C-mediated abolishment of fast inactivation is not due to the 
dissociation of Kv1.5 and Kvβ1.3. Finally, immunoprecipitation and immunocytochemistry experiments revealed an 
association between Kv1.5, Kvβ1.3, the receptor for activated C kinase (RACK1), PKCβI, PKCβII, and PKCθ in 
HEK293 cells. A very similar Kv1.5 channelosome was found in rat ventricular tissue but not in atrial tissue. J Biol 
Chem. 2012 Jun 15;287(25):21416-28.  
 
9.2 Reviews 
 
Kv1.5-Kv beta interactions: molecular determinants and pharmacological consequences.  
González T, David M, Moreno C, Macías A, Valenzuela C.  
Abstract: Kv1.5 channels are homotetramers of alpha-pore subunits mainly present in human atrium and 
pulmonary vasculature. Thus, Kv1.5 is a pharmacological target for cardiovascular diseases. Kv beta 1.3 
assemblies with Kv alpha 1.5 and modifies its gating and pharmacology. A further knowledge of alpha-beta 
interactions and pharmacology will lead a better design of new drugs. Mini Rev Med Chem. 2010 Jun;10(7):635-
42. 
 
Stereoselective interactions between local anesthetics and ion channels. 
Valenzuela C, Moreno C, de la Cruz A, Macías Á, Prieto Á, González T.Abstract: Local anesthetics are useful 
probes of ion channel function and structure. Stereoselective interactions are especially interesting because they 
can reveal three-dimensional relationships between drugs and channels with otherwise identical biophysical and 
physicochemical properties. Furthermore, stereoselectivity suggests direct and specific receptor-mediated action, 
and identification of such stereospecific interactions may have important clinical consequences. The fact that drug 
targets are able to discriminate between the enantiomers present in a racemic drug is the consequence of the 
ordered asymmetric macromolecular units that form living cells. However, almost 25% of the drugs used in the 
clinical practice are racemic mixtures, and their individual enantiomers frequently differ in both their 
pharmacodynamic and pharmacokinetic profiles. Moreover, their effects can be similar to or different from the 
pharmacological effect of the drug and may contribute to the undesired effects of the drug. In other cases, the 
pharmacological effects induced by the two enantiomers on the molecular target are opposite. In the present 
manuscript, we will review the stereoselective effects of bupivacaine-like local anesthetics on cardiac sodium and 
potassium channels. Chirality. 2012 Nov;24(11):944-50.  
 
Effects of n-3 Polyunsaturated Fatty Acids on Cardiac Ion Channels 
Moreno C, Macías A, Prieto A, de la Cruz A, González T, Valenzuela C. 
Abstract: Dietary n-3 polyunsaturated fatty acids (PUFAs) have been reported to exhibit antiarrhythmic properties, 
and these effects have been attributed to their capability to modulate ion channels. In the present review, we will 
focus on the effects of PUFAs on a cardiac sodium channel (Nav1.5) and two potassium channels involved in 
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cardiac atrial and ventricular repolarization (Kv) (Kv1.5 and Kv11.1). n-3 PUFAs of marine (docosahexaenoic, DHA 
and eicosapentaenoic acid, EPA) and plant origin (alpha-linolenic acid, ALA) block Kv1.5  and Kv11.1 channels at 
physiological concentrations. Moreover, DHA and EPA decrease the expression levels of Kv1.5, whereas ALA 
does not. DHA and EPA also decrease the magnitude of the currents elicited by the activation of Kv1.5 and 
calcium channels. These effects on sodium and calcium channels should theoretically shorten the cardiac action 
potential duration (APD), whereas the blocking actions of n-3 PUFAs on Kv channels would be expected to 
produce a lengthening of cardiac action potential. Indeed, the effects of n-3 PUFAs on the cardiac APD and, 
therefore, on cardiac arrhythmias vary depending on the method of application, the animal model, and the 
underlying cardiac pathology. Front Physiol. 2012;3:245.  
 
Polyunsaturated Fatty acids modify the gating of kv channels. 
Moreno C, Macias A, Prieto A, De La Cruz A, Valenzuela C. 
Abstract: Polyunsaturated fatty acids (PUFAs) have been reported to exhibit antiarrhythmic properties, which are 
attributed to their capability to modulate ion channels. This PUFAs ability has been reported to be due to their 
effects on the gating properties of ion channels. In the present review, we will focus on the role of PUFAs on the 
gating of two Kv channels, Kv1.5 and Kv11.1. Kv1.5 channels are blocked by n-3 PUFAs of marine 
(docosahexaenoic acid (DHA) and eicosapentaenoic acid] and plant origin (alpha-linolenic acid, ALA) at 
physiological concentrations. The blockade of Kv1.5 channels by PUFAs steeply increased in the range of 
membrane potentials coinciding with those of Kv1.5 channel activation, suggesting that PUFAs-channel binding 
may derive a significant fraction of its voltage sensitivity through the coupling to channel gating. A similar shift in 
the activation voltage was noted for the effects of n-6 arachidonic acid (AA) and DHA on Kv1.1, Kv1.2, and Kv11.1 
channels. PUFAs- Kv1.5 channel interaction is time-dependent, producing a fast decay of the current upon 
depolarization. Thus, Kv1.5 channel opening is a prerequisite for the PUFA-channel interaction. Similar to the 
Kv1.5 channels, the blockade of Kv11.1 channels by AA and DHA steeply increased in the range of membrane 
potentials that coincided with the range of Kv11.1 channel activation, suggesting that the PUFAs- Kv channel 
interactions are also coupled to channel gating. Furthermore, AA regulates the inactivation process in other Kv 
channels, introducing a fast voltage-dependent inactivation in non-inactivating Kv channels. These results have 
been explained within the framework that AA closes voltage-dependent potassium channels by inducing 
conformational changes in the selectivity filter, suggesting that Kv channel gating is lipid dependent. Front 
Pharmacol. 2012;3:163. 
 
9.3 Publications in progress  
 
Modulation of Kv and Kir currents by 15-epi-lipoxin-A4 in activated murine macrophages. 
Implications in innate immunity  
Moreno C,║ Prieto P,║ Macías A,║ Santillana MP,║ Través PG, Boscá L,¶ and Valenzuela C.¶ ║ CM, PP, AM and 
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MP-S contributed equally to this work. ¶ Corresponding authors 
Abstract: Potassium channels play a pivotal role in the modulation of macrophage physiology. Blockade of 
voltage dependent potassium channels (Kv) channels by specific antagonists decreases macrophage cytokine 
production and inhibits proliferation. In the presence of aspirin, acetylated COX-2 loses activity required to form 
prostaglandin but maintains oxygenase activity to produce 15R-HETE from arachidonate. This intermediate 
product is transformed via 5-LOX into epimeric lipoxins, termed 15-epi-lipoxins (e-LXA4). Kv channels have been 
proposed as anti-inflammatory targets. Therefore, we studied the effects of e-LXA4 on early signaling and on Kv 
and inward rectifier potassium channels (Kir) in mice bone marrow-derived macrophages (BMDM). Experiments 
were performed in BMDM and electrophysiological recordings were performed by the whole-cell patch-clamp 
technique. Treatment of BMDM with e-LXA4 inhibited LPS-dependent activation of NF-κB and IKKβ activity, at the 
same time that protected against LPS activation-dependent apoptosis. In addition, acute treatment of LPS-
stimulated BMDM with e-LXA4 resulted in a decrease of Kv currents, compatible with attenuation of the 
inflammatory response. More importantly, long-term treatment of LPS-stimulated BMDM with e-LXA4 significantly 
reverted LPS effects on Kv and Kir currents. Under these conditions, e-LXA4 decreased calcium influx vs. that 
observed in LPS-stimulated BMDM. These effects were mediated, at least in part, via the lipoxin receptor (ALX), 
since were partially reverted in the presence of a selective ALX receptor antagonist. We provide evidence for a 
new mechanism by which e-LXA4 contributes to inflammation resolution consisting in the reversion of LPS effects 
on Kv and Kir currents in macrophages. 
 
Effects of n-3 polyunsaturated fatty acids on the function, expression and localization of Kv7.1 
channels 
Moreno C, Oliveras A, Kharche S, Guizy M, Comes N, Starý T, Loussouarn G, Severi S, Felipe A, Valenzuela C. 
Abstract: Dietary polyunsaturated fatty acids (PUFAs) have been reported to exhibit antiarrhythmic properties, 
which have been attributed to their ability to modulate ion channels. In this work we analyzed the effects of EPA 
and DHA on the current and the expression of Kv7.1+KCNE1 channels transiently expressed in COS7 cells by 
using patch-clamp, Western blot, and lipid rafts extraction techniques. Perfusion of cells with EPA and DHA (20 
μM) increased Kv7.1+KCNE1 current. This effect was accompanied by an acceleration of the deactivation kinetics 
and slower activation kinetics. Both PUFAs shifted the activation curve towards negative potentials. After 
incubation the cells during 48 h with EPA, Kv7.1 current magnitude decreased and the activation curve was 
shifted to more positive potentials. Under these conditions, EPA decreased the expression of Kv7.1 but not of 
KCNE1. This decrease in the Kv7.1 protein expression was prevented in the presence of a proteasome inhibitor 
MG132, suggesting that PUFAs can favor a degradation of Kv7.1 via proteasome. Also, DHA and EPA impaired 
the localization of Kv7.1 in lipid rafts. Electrophysiological experiments with methyl-β-cyclodextrin (MβCD) 
demonstrated that removal of cholesterol with MβCD increased the Kv7.1 magnitude current. After cholesterol 
depletion with MβCD, EPA produces similar effects than those produced acutely and they could be reverted after 
wash-out with external drug-free solution, suggesting a direct effect on the channel. These results demonstrate 
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that EPA and DHA: 1) increase the Kv7.1+KCNE1 magnitude, 2) induce Kv7.1 degradation via proteasome and 3) 
modify the membrane localization of this channel. 
 
A New KCNQ1 mutation responsible of short QT syndrome located at the S5 segment 
Moreno C, Muñoz C, de la Cruz A, Salar M, Gimeno JR, Lambiasse P, Felipe A, Valenzuela C. 
Abstract: Mutations involving cardiac ion channels result in abnormal action potential (AP) formation or 
propagation, leading to cardiac arrhythmias. They constitute approximately 10–20% of all sudden cardiac death 
(SCD). The short QT syndrome is a new congenital entity characterized by a shortened QTc interval in the ECG 
and a lack of adaptation during increasing heart rates. In the present Doctoral Thesis, we used the patch-clamp 
technique to characterize the novel F279I Kv7.1 mutation found on a 23 years old man with a QTc of 356 ms and 
a familial history of SCD. In the absence of KCNE1, WT and F279I Kv7.1 currents had similar biophysical 
properties. However, functional analysis of F279I Kv7.1 (alone or co-expressed with the WT channel, in the 
presence of KCNE1) revealed a pronounced shift of the half-activation potential and an acceleration of the 
activation kinetics leading to a gain of function in IKs. We conclude that the F279I mutation would predict to 
augment substantially repolarizing current during the AP due to an impaired coupling of the Kv7.1 gating 
modulation induced by KCNE1. 
 
 
